Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  HIV Infection

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 528 articles:
HTML format



Single Articles


    March 2024
  1. VALIN N, Lambert-Niclot S, Torres E, Meynard JL, et al
    A Human Immunodeficiency Virus Superinfection Diagnosed in a Patient on Intramuscular Long-acting Combination of Cabotegravir and Rilpivirine.
    Clin Infect Dis. 2024 Mar 21:ciad757. doi: 10.1093.
    PubMed     Abstract available


  2. BOODMAN C, Gupta N, Nelson CA, van Griensven J, et al
    Bartonella quintana Endocarditis: A Systematic Review of Individual Cases.
    Clin Infect Dis. 2024;78:554-561.
    PubMed     Abstract available


  3. KRISHNAN S, Chaisson RE
    US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
    Clin Infect Dis. 2024;78:514-517.
    PubMed     Abstract available


  4. VANBAELEN T, Tsoumanis A, Kenyon C
    Total Antimicrobial Consumption in Doxycycline Postexposure Prophylaxis Cohorts and the Intensity of Screening for Bacterial Sexually Transmitted Infections.
    Clin Infect Dis. 2024;78:803-805.
    PubMed    


  5. NGUYEN Q, Wooten D, Lee D, Moreno M, et al
    GLP-1 Receptor Agonists Promote Weight Loss Among People with HIV.
    Clin Infect Dis. 2024 Mar 19:ciae151. doi: 10.1093.
    PubMed     Abstract available


  6. HAZRA A, Celum C, Luetkemeyer AF, Molina JM, et al
    Risk of antimicrobial resistance with doxy-PEP is real, as is the need for its well-Informed implementation.
    Clin Infect Dis. 2024 Mar 19:ciae152. doi: 10.1093.
    PubMed    


  7. KENYON C
    We should not downplay the risks that doxycycline PEP will select for AMR.
    Clin Infect Dis. 2024 Mar 19:ciae139. doi: 10.1093.
    PubMed    


  8. LANDOVITZ RJ, Tao L, Yang J, de Boer M, et al
    HIV-1 Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Pooled Analysis From 72 Global Studies.
    Clin Infect Dis. 2024 Mar 14:ciae143. doi: 10.1093.
    PubMed     Abstract available


  9. MINTER DJ, Appa A, Chambers HF, Doernberg SB, et al
    The positioning of ceftobiprole in the treatment of Staphylococcus aureus bacteremia.
    Clin Infect Dis. 2024 Mar 11:ciae126. doi: 10.1093.
    PubMed    


  10. NGO HX, Xu AY, Velasquez GE, Zhang N, et al
    Pharmacokinetic-Pharmacodynamic Evidence from a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
    Clin Infect Dis. 2024 Mar 11:ciae119. doi: 10.1093.
    PubMed     Abstract available


    February 2024
  11. CROCKER-BUQUE T, Lachenal N, Narasimooloo C, Abdrasuliev T, et al
    Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL.
    Clin Infect Dis. 2024 Feb 29:ciad767. doi: 10.1093.
    PubMed    


  12. TEIXEIRA LAA, Santos B, Correia MG, Valiquette C, et al
    Long-term protective effect of tuberculosis preventive therapy in a medium/high TB incidence setting.
    Clin Infect Dis. 2024 Feb 26:ciae101. doi: 10.1093.
    PubMed     Abstract available


  13. SALDANA CS, Burkhardt E, Pennisi A, Oliver K, et al
    Development of a Machine Learning Modelling Tool for Predicting HIV Incidence Using Public Health Data from a County in the Southern United States.
    Clin Infect Dis. 2024 Feb 23:ciae100. doi: 10.1093.
    PubMed     Abstract available


  14. AGGARWAL NR, Nordwall J, Braun DL, Chung L, et al
    Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
    Clin Infect Dis. 2024 Feb 20:ciad780. doi: 10.1093.
    PubMed     Abstract available


  15. KATO Y, Ambale-Venkatesh B, Naveed M, Shitole SG, et al
    HIV, HIV-specific Factors and Myocardial Disease in Women.
    Clin Infect Dis. 2024 Feb 13:ciae077. doi: 10.1093.
    PubMed     Abstract available


  16. HAZRA A, McNulty MC, Pyra M, Pagkas-Bather J, et al
    Filling in the Gaps: Updates on Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections.
    Clin Infect Dis. 2024 Feb 9:ciae062. doi: 10.1093.
    PubMed     Abstract available


  17. SLAMA L, Barrett BW, Abraham AG, Palella FJ Jr, et al
    Incident Proteinuria differs by HIV Serostatus among Men with Pre-diabetes: The Multicenter AIDS Cohort Study.
    Clin Infect Dis. 2024 Feb 9:ciae065. doi: 10.1093.
    PubMed     Abstract available


  18. MILBURN J, Ntwayagae O, Suresh R, Ngoni K, et al
    Tracking cryptococcal meningitis to monitor HIV program success during the Treat-All era: an analysis of national data in Botswana.
    Clin Infect Dis. 2024 Feb 8:ciae066. doi: 10.1093.
    PubMed     Abstract available


  19. CHAMBERS HF, Zhang S, Evans S
    Duke Infective Endocarditis Criteria 3.0 for the Clinician: Defining What Is Possible.
    Clin Infect Dis. 2024 Feb 8:ciae037. doi: 10.1093.
    PubMed    


  20. MARINELLI T, Masters J, Buckland ME, Lee M, et al
    Chronic and neurotropic: A paradigm-challenging case of dengue virus encephalitis in patient with advanced human immunodeficiency virus infection.
    Clin Infect Dis. 2024 Feb 6:ciae061. doi: 10.1093.
    PubMed     Abstract available


  21. BETTONTE S, Berton M, Stader F, Battegay M, et al
    Effect of obesity on the exposure of long-acting cabotegravir and rilpivirine: a modelling study.
    Clin Infect Dis. 2024 Feb 3:ciae060. doi: 10.1093.
    PubMed     Abstract available


  22. STEADMAN A, Andama A, Ball A, Mukwatamundu J, et al
    New manual qPCR assay validated on tongue swabs collected and processed in Uganda shows sensitivity that rivals sputum-based molecular TB diagnostics.
    Clin Infect Dis. 2024 Feb 2:ciae041. doi: 10.1093.
    PubMed     Abstract available


  23. BIELICK C, Strumpf A, Ghosal S, McMurry T, et al
    National Hospitalization Rates and In-Hospital Mortality Rates of HIV-related Opportunistic Infections in the United States, 2011-2018.
    Clin Infect Dis. 2024 Feb 2:ciae051. doi: 10.1093.
    PubMed     Abstract available


    January 2024
  24. VARLEY CD, Lowy E, Cartwright EJ, Morgan TR, et al
    Success of the US Veterans Health Administration's Hepatitis C Virus Care Continuum in the Direct-acting Antiviral Era.
    Clin Infect Dis. 2024 Jan 27:ciae025. doi: 10.1093.
    PubMed     Abstract available


  25. POWELL A, Agwu A
    In Support of Breast/Chest Feeding by People with HIV in High-Income Settings.
    Clin Infect Dis. 2024 Jan 25:ciae027. doi: 10.1093.
    PubMed     Abstract available


  26. WANG R, Sun L, Wang X, Zhai Y, et al
    Rapid Initiation of Antiretroviral Therapy with Coformulated Bictegravir, Emtricitabine, Tenofovir Alafenamide Versus Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate in HIV-positive Men Who Have Sex with Men in China: Week 48 Results of the Mu
    Clin Infect Dis. 2024 Jan 17:ciae012. doi: 10.1093.
    PubMed     Abstract available


  27. SILVERBERG MJ, Levine TM, Lea AN, Williams AE, et al
    Cardiovascular Disease Risk Factor Control in People With and Without Human Immunodeficiency Virus.
    Clin Infect Dis. 2024 Jan 16:ciad728. doi: 10.1093.
    PubMed     Abstract available


  28. MARQUEZ C, Atukunda M, Nugent J, Charlebois ED, et al
    Community-Wide Universal Human Immunodeficiency Virus (HIV) Test and Treat Intervention Reduces Tuberculosis Transmission in Rural Uganda: A Cluster-Randomized Trial.
    Clin Infect Dis. 2024 Jan 16:ciad776. doi: 10.1093.
    PubMed     Abstract available


  29. WEBER MSR, Duran Ramirez JJ, Hentzien M, Cavassini M, et al
    Time Trends in Causes of Death in People with HIV: Insights from the Swiss HIV Cohort Study.
    Clin Infect Dis. 2024 Jan 12:ciae014. doi: 10.1093.
    PubMed     Abstract available


  30. VAN WELZEN BJ, Van Lelyveld SFL, Ter Beest G, Gisolf JH, et al
    Virological failure after switch to long-acting cabotegravir and rilpivirine injectable therapy: an in-depth analysis.
    Clin Infect Dis. 2024 Jan 11:ciae016. doi: 10.1093.
    PubMed     Abstract available


  31. URSENBACH A, Ruch Y, Hoellinger B, Fuchs A, et al
    Two cases of viral re-suppression after M184V + R263 K selection on DTG/3TC without treatment modification.
    Clin Infect Dis. 2024 Jan 9:ciae006. doi: 10.1093.
    PubMed     Abstract available


  32. VAN GRIENSVEN J, van Henten S, Kibret A, Kassa M, et al
    Chronic high level parasitemia in HIV-infected individuals with or without visceral leishmaniasis in an endemic area in North-West Ethiopia: potential superspreaders?
    Clin Infect Dis. 2024 Jan 9:ciae002. doi: 10.1093.
    PubMed     Abstract available


  33. NACHMAN S, Aldrovandi G
    Breastfeeding in the United States Among Women With HIV: Con Viewpoint.
    Clin Infect Dis. 2024 Jan 8:ciad778. doi: 10.1093.
    PubMed     Abstract available


  34. HOFFMAN RM, Brummel S, Ziemba L, Chinula L, et al
    Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum.
    Clin Infect Dis. 2024 Jan 5:ciae001. doi: 10.1093.
    PubMed     Abstract available


    December 2023
  35. KOSANA P, Wu K, Tassiopoulos K, Letendre S, et al
    Polypharmacy is associated with slow gait speed and recurrent falls in older people with HIV.
    Clin Infect Dis. 2023 Dec 26:ciad782. doi: 10.1093.
    PubMed     Abstract available


  36. ROSEN JG, Ndyanabo A, Nakawooya H, Galiwango RM, et al
    Incidence of health facility switching and associations with HIV viral rebound among persons on antiretroviral therapy (ART) in Uganda: a population-based study.
    Clin Infect Dis. 2023 Dec 19:ciad773. doi: 10.1093.
    PubMed     Abstract available


  37. ROSE MR, Dowdy DW
    High Specificity and Low Prevalence - Important Context for HIV Testing in US Cancer Patients.
    Clin Infect Dis. 2023 Dec 19:ciad774. doi: 10.1093.
    PubMed    


  38. CHIU CY, Jiang Y, Torres HA
    Reply to "High Specificity and Low Prevalence - Important Context for HIV Testing in US Cancer Patients".
    Clin Infect Dis. 2023 Dec 19:ciad775. doi: 10.1093.
    PubMed    


  39. CHAMMARTIN F, Mocroft A, Egle A, Zangerle R, et al
    Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral Treated People With Human Immunodeficiency Virus (HIV).
    Clin Infect Dis. 2023 Dec 13:ciad671. doi: 10.1093.
    PubMed     Abstract available


  40. MANNE-GOEHLER J, Ali MK, Flood D, Marconi VC, et al
    From Evidence to Effectiveness: Implications of the Randomized Trial to Prevent Vascular Events in HIV Study for People With Human Immunodeficiency Virus in Low- and Middle-Income Settings.
    Clin Infect Dis. 2023 Dec 8:ciad702. doi: 10.1093.
    PubMed     Abstract available


  41. LIN KY, Sun HY, Yang CJ, Lu PL, et al
    Treatment responses to integrase strand-transfer inhibitor-containing antiretroviral regimens in combination with short-course rifapentine-based regimens for latent tuberculosis infection among people with HIV.
    Clin Infect Dis. 2023 Dec 5:ciad730. doi: 10.1093.
    PubMed     Abstract available


  42. CHAMIE G, Luetkemeyer AF
    Daily second-generation INSTIs and short-course TPT: What more do we need to know?
    Clin Infect Dis. 2023 Dec 5:ciad726. doi: 10.1093.
    PubMed    


  43. HOFFMANN CJ, Shearer K, Kekana B, Kerrigan D, et al
    Reducing HIV-associated post-hospital mortality through home-based care in South Africa: a randomized controlled trial.
    Clin Infect Dis. 2023 Dec 5:ciad727. doi: 10.1093.
    PubMed     Abstract available


    November 2023
  44. JAIN V
    Infection Control and Prevention During the COVID-19 Pandemic.
    Clin Infect Dis. 2023 Nov 30:ciad611. doi: 10.1093.
    PubMed    


  45. MINTER DJ, Appa A, Chambers HF, Doernberg SB, et al
    Executive Summary: State-of-The-Art Review: Contemporary Management of Staphylococcus aureus Bacteremia: Controversies in Clinical Practice.
    Clin Infect Dis. 2023;77:1489-1491.
    PubMed    


  46. THAKARAR K, Appa A, Abdul Mutakabbir JC, Goff A, et al
    Frame Shift: Focusing on Harm Reduction and Shared Decision Making for People Who Use Drugs Hospitalized With Infections.
    Clin Infect Dis. 2023 Nov 29:ciad664. doi: 10.1093.
    PubMed    


  47. THAKARAR K, Appa A, Abdul Mutakabbir JC, Goff A, et al
    Executive Summary: State-of-the-Art Review: Frame Shift-Focusing on Harm Reduction and Shared Decision Making for People Who Use Drugs Hospitalized With Infections.
    Clin Infect Dis. 2023 Nov 29:ciad665. doi: 10.1093.
    PubMed    


  48. VINIKOOR MJ, Hamusonde K, Muula G, Asombang M, et al
    Long-term hepatitis B and liver outcomes among adults taking tenofovir-containing antiretroviral therapy for HBV/HIV coinfection in Zambia.
    Clin Infect Dis. 2023 Nov 24:ciad654. doi: 10.1093.
    PubMed     Abstract available


  49. GAUSI K, Mugerwa H, Siccardi M, Montanha MC, et al
    Pharmacokinetics and safety of twice-daily ritonavir-boosted atazanavir with rifampicin.
    Clin Infect Dis. 2023 Nov 20:ciad700. doi: 10.1093.
    PubMed     Abstract available


  50. MISRA K, Huang JS, Udeagu CN, Forgione L, et al
    Pre-exposure prophylaxis (PrEP) use history in people with antiretroviral resistance at HIV diagnosis: Findings from New York City HIV surveillance and partner services, 2015-2022.
    Clin Infect Dis. 2023 Nov 17:ciad699. doi: 10.1093.
    PubMed     Abstract available


  51. MANHART LE, Leipertz G, Soge OO, Jordan SJ, et al
    Mycoplasma genitalium in the US (MyGeniUS): Surveillance Data From Sexual Health Clinics in 4 US Regions.
    Clin Infect Dis. 2023;77:1449-1459.
    PubMed     Abstract available


  52. SWARTZ TH, Aberg JA
    Preserving the Future of Infectious Diseases: Why We Must Address the Decline in Compensation for Clinicians and Researchers.
    Clin Infect Dis. 2023;77:1387-1394.
    PubMed     Abstract available


  53. ADACHI E, Owada R, Sato S, Kono M, et al
    Febrile gluteal inflammation evident on imaging findings after long-acting cabotegravir administration.
    Clin Infect Dis. 2023 Nov 16:ciad705. doi: 10.1093.
    PubMed    


  54. SPINELLI MA, Christopoulos KA, Moreira CV, Jain JP, et al
    Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2023 Nov 14:ciad657. doi: 10.1093.
    PubMed     Abstract available


  55. MINTER DJ, Appa A, Chambers HF, Doernberg SB, et al
    Contemporary Management of Staphylococcus aureus Bacteremia-Controversies in Clinical Practice.
    Clin Infect Dis. 2023 Nov 10:ciad500. doi: 10.1093.
    PubMed     Abstract available


  56. CHEN YR, Zheng CX, Chen TY, Wei JC, et al
    Comment on "Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection.".
    Clin Infect Dis. 2023 Nov 8:ciad675. doi: 10.1093.
    PubMed    


  57. CHIU CY, Mustafayev K, Bhatti MM, Jiang Y, et al
    False-Reactive Fourth-Generation Human Immunodeficiency Virus Testing in Cancer Patients.
    Clin Infect Dis. 2023 Nov 1:ciad608. doi: 10.1093.
    PubMed     Abstract available


    October 2023
  58. JACOBS TG, Mumbiro V, Cassia U, Zimba K, et al
    Twice-daily dosing of dolutegravir in infants on rifampicin treatment: a pharmacokinetic substudy of the EMPIRICAL trial.
    Clin Infect Dis. 2023 Oct 26:ciad656. doi: 10.1093.
    PubMed     Abstract available


  59. BROWN TS, Tang L, Omar SV, Joseph L, et al
    Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis.
    Clin Infect Dis. 2023 Oct 24:ciad596. doi: 10.1093.
    PubMed     Abstract available


  60. FONTAN-VELA M, Hernando V, Olmedo C, Coma E, et al
    Effectiveness of MVA-BN vaccination in a population at high-risk of mpox: a Spanish cohort study.
    Clin Infect Dis. 2023 Oct 21:ciad645. doi: 10.1093.
    PubMed     Abstract available


  61. AMICK AK, Eskibozkurt GE, Hosek SG, Flanagan CF, et al
    Daily Oral Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price.
    Clin Infect Dis. 2023 Oct 12:ciad566. doi: 10.1093.
    PubMed     Abstract available


  62. CASTRO H, Sabin C, Collins IJ, Okhai H, et al
    Evolution of CD4 T-Cell count with age in a cohort of young people growing up with perinatally acquired HIV.
    Clin Infect Dis. 2023 Oct 11:ciad626. doi: 10.1093.
    PubMed     Abstract available


  63. STIER EA, Jain M, Joshi H, Darragh TM, et al
    Two-Year Incidence and Cumulative Risk and Predictors of Anal High-Grade Squamous Intraepithelial Lesions (anal precancer) among Women with HIV.
    Clin Infect Dis. 2023 Oct 8:ciad614. doi: 10.1093.
    PubMed     Abstract available


  64. HAYON J, Lupo S, Poveda C, Jones KM, et al
    Adaptation of Chagas Disease Screening Recommendations for a Community of At-risk People with HIV Living in the United States.
    Clin Infect Dis. 2023 Oct 8:ciad616. doi: 10.1093.
    PubMed     Abstract available


  65. HAVLIR DV
    My Personal Calling.
    Clin Infect Dis. 2023 Oct 4:ciad542. doi: 10.1093.
    PubMed    


  66. SUNG J, Nantale M, Nalutaaya A, Biche P, et al
    Evidence for tuberculosis in individuals with Xpert Ultra "trace" sputum during screening of high-burden communities.
    Clin Infect Dis. 2023 Oct 3:ciad595. doi: 10.1093.
    PubMed     Abstract available


    September 2023
  67. SAUER SM, Mitnick CD, Khan U, Hewison C, et al
    Estimating post-treatment recurrence after multidrug-resistant tuberculosis treatment among patients with and without HIV: the impact of assumptions about death and missing follow-up.
    Clin Infect Dis. 2023 Sep 29:ciad589. doi: 10.1093.
    PubMed     Abstract available


  68. GUPTA A, Hughes MD, Cruz JL, Avihingsanon A, et al
    Adverse Pregnancy Outcomes among HIV-infected Women Taking Isoniazid Preventive Therapy During the First Trimester.
    Clin Infect Dis. 2023 Sep 28:ciad583. doi: 10.1093.
    PubMed     Abstract available


  69. BROCK JB, Herrington P, Hickman M, Hickman A, et al
    Long-acting Injectable Cabotegravir/Rilpivirine Effective in a Small Patient Cohort With Virologic Failure on Oral Antiretroviral Therapy.
    Clin Infect Dis. 2023 Sep 22:ciad511. doi: 10.1093.
    PubMed     Abstract available


  70. MEYEROWITZ EA, Mukerji SS, Kyle Harrold G, Erdil RM, et al
    Mogamulizumab for Treatment of Human T-lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Single-Center US-based Series.
    Clin Infect Dis. 2023;77:851-856.
    PubMed     Abstract available


  71. BARES SH, Wu X, Tassiopoulos K, Lake JE, et al
    Weight gain after antiretroviral therapy initiation and subsequent risk of metabolic and cardiovascular disease.
    Clin Infect Dis. 2023 Sep 12:ciad545. doi: 10.1093.
    PubMed     Abstract available


  72. COSTAGLIOLA D
    Cardiovascular Diseases and Exposure to Integrase Inhibitors: Causal Interpretation of Treatment Effect in Observational Studies.
    Clin Infect Dis. 2023;77:738-739.
    PubMed    


  73. SHARMA I, Hill A
    Global HIV Incidence Analysis and Implications for Affordability using CAB-LA versus Continuous and Event-Driven Oral PrEP.
    Clin Infect Dis. 2023 Sep 4:ciad537. doi: 10.1093.
    PubMed     Abstract available


  74. CUZIN L, Morisot A, Allavena C, Lert F, et al
    Drastic reduction in time to controlled viral load in people with HIV in France (2009-2019): a longitudinal cohort study.
    Clin Infect Dis. 2023 Sep 4:ciad530. doi: 10.1093.
    PubMed     Abstract available


    August 2023
  75. TAO Y, Tang W, Fajardo E, Cheng M, et al
    Reflex Hepatitis C Virus Viral Load Testing Following an Initial Positive Hepatitis C Virus Antibody Test: A Global Systematic Review and Meta-analysis.
    Clin Infect Dis. 2023 Aug 31:ciad126. doi: 10.1093.
    PubMed     Abstract available


  76. CHEN KH, Sun HY, Chen CH, Chuang YC, et al
    Higher serologic responses of early syphilis to single-dose benzathine penicillin G plus doxycycline versus single-dose benzathine penicillin G alone among people with HIV.
    Clin Infect Dis. 2023 Aug 27:ciad508. doi: 10.1093.
    PubMed     Abstract available


  77. KAPADIA SN, Jordan AE, Eckhardt BJ, Perlman DC, et al
    The urgent need to implement point-of-care RNA testing for hepatitis C virus to support elimination.
    Clin Infect Dis. 2023 Aug 27:ciad503. doi: 10.1093.
    PubMed     Abstract available


  78. GRAS J, Helary M, Carette D, Minier M, et al
    Prevalence, Risk factors, and Shedding of Human Herpes Virus-8 among Men Having Sex With Men Enrolled in a Pre-exposure Prophylaxis Study.
    Clin Infect Dis. 2023 Aug 25:ciad502. doi: 10.1093.
    PubMed     Abstract available


  79. BOULWARE DR, Atukunda M, Kagimu E, Musubire AK, et al
    Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial.
    Clin Infect Dis. 2023 Aug 22:ciad440. doi: 10.1093.
    PubMed     Abstract available


  80. FOURGEAUD J, Lecuit MM, Perot P, Bruneau J, et al
    Chronic Aichi Virus Infection As a Cause of Long-Lasting Multiorgan Involvement in Patients With Primary Immune Deficiencies.
    Clin Infect Dis. 2023;77:620-628.
    PubMed     Abstract available


  81. BERTON M, Bettonte S, Stader F, Decosterd L, et al
    Antiretroviral drug exposure and response in obese and morbidly obese people with HIV: a study combining modelling and Swiss HIV Cohort data.
    Clin Infect Dis. 2023 Aug 21:ciad495. doi: 10.1093.
    PubMed     Abstract available


  82. PERSON AK, Terndrup CP, Jain MK, Kelley CF, et al
    "Do We Stay or Do We Go?" The Impact of anti-LGBTQ+ Legislation on the HIV Workforce in the South.
    Clin Infect Dis. 2023 Aug 19:ciad493. doi: 10.1093.
    PubMed     Abstract available


  83. TRAEGER MW, Mayer KH, Krakower DS, Gitin S, et al
    Potential impact of doxycycline post-exposure prophylaxis prescribing strategies on incidence of bacterial sexually transmitted infections.
    Clin Infect Dis. 2023 Aug 18:ciad488. doi: 10.1093.
    PubMed     Abstract available


  84. PHILPOTT DC, Bonacci RA, Weidle PJ, Curran KG, et al
    Low CD4 Count or Being Out of Care Increases the Risk for Mpox Hospitalization Among People with HIV and Mpox.
    Clin Infect Dis. 2023 Aug 17:ciad482. doi: 10.1093.
    PubMed     Abstract available


  85. NIU X, Drain PK
    Is Higher Adherence Required for Women using Oral Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Preexposure Prophylaxis?
    Clin Infect Dis. 2023 Aug 17:ciad485. doi: 10.1093.
    PubMed    


  86. FELD JJ, Bruneau J, Dore GJ, Ghany MG, et al
    Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available


  87. MARTINELLO M, Naggie S, Rockstroh JK, Matthews GV, et al
    Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative Review.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available


  88. WALLES J, Winqvist N, Hansson SR, Sturegard E, et al
    Pregnancy outcomes in women screened for tuberculosis infection in Swedish antenatal care.
    Clin Infect Dis. 2023 Aug 12:ciad465. doi: 10.1093.
    PubMed     Abstract available


  89. ZHUANG Y, Wang M, Liang L, Mao Y, et al
    The first known human death after infection with the avian influenza (A/H3N8) virus: Guangdong Province, China, March 2023.
    Clin Infect Dis. 2023 Aug 9:ciad462. doi: 10.1093.
    PubMed     Abstract available


  90. SACK DE, Brantley M, Ratliff M, Mathieson S, et al
    Misclassification of Loss to Care Among Persons with HIV: Improved Capture of Silent Transfers through Surveillance Linkage using Statewide Mandatorily Reported Laboratory Measures.
    Clin Infect Dis. 2023 Aug 9:ciad461. doi: 10.1093.
    PubMed     Abstract available


  91. SCHOMAKER M, Kerschberger B, Boulle A
    Response to "Treatment Outcomes After Offering Same-Day Initiation of Human Immunodeficiency Virus (HIV) Treatment-How to Interpret Discrepancies Between Different Studies".
    Clin Infect Dis. 2023 Aug 5:ciad459. doi: 10.1093.
    PubMed    


  92. BROUGH J, Martinez L, Hatherill M, Zar HJ, et al
    Public health impact and cost-effectiveness of screening for active tuberculosis disease or infection among children in South Africa.
    Clin Infect Dis. 2023 Aug 5:ciad449. doi: 10.1093.
    PubMed     Abstract available


    July 2023
  93. HAN WM, Apornpong T, Su Lwin HM, Thammapiwan S, et al
    Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis with liver fibrosis as predictors of new-onset Diabetes Mellitus in People living with HIV: A Longitudinal Cohort Study.
    Clin Infect Dis. 2023 Jul 21:ciad433. doi: 10.1093.
    PubMed     Abstract available


  94. VOLLMOND CV, Tetens MM, Paulsen FW, Gerstoft J, et al
    Risk of Depression in People With HIV: A nationwide population-based matched cohort study.
    Clin Infect Dis. 2023 Jul 19:ciad415. doi: 10.1093.
    PubMed     Abstract available


  95. GARCIA R, Warming PE, Hansen CJ, Rajan D, et al
    Out-of-Hospital Cardiac Arrest in individuals with Human Immunodeficiency Virus infection - A nationwide population-based cohort study.
    Clin Infect Dis. 2023 Jul 14:ciad422. doi: 10.1093.
    PubMed     Abstract available


  96. FOLDYNA B, Mayrhofer T, Zanni MV, Lyass A, et al
    Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People with HIV in the REPRIEVE Cohort.
    Clin Infect Dis. 2023 Jul 13:ciad419. doi: 10.1093.
    PubMed     Abstract available


  97. NARAYANASAMY S, Curtis LH, Hernandez AF, Woods CW, et al
    Lessons from COVID-19 for Pandemic Preparedness: Proceedings from a Multi-Stakeholder Think Tank.
    Clin Infect Dis. 2023 Jul 12:ciad418. doi: 10.1093.
    PubMed     Abstract available


  98. MATUSALI G, Mazzotta V, Piselli P, Bettini A, et al
    Asymptomatic Mpox infection in subjects presenting for MVA-BN vaccine.
    Clin Infect Dis. 2023 Jul 7:ciad414. doi: 10.1093.
    PubMed    


  99. LEWIS KC, Barker LK, Jiles R, Gupta N, et al
    Estimated prevalence and awareness of hepatitis C virus infection among U.S. adults- National Health and Nutrition Examination Survey, January 2017-March 2020.
    Clin Infect Dis. 2023 Jul 7:ciad411. doi: 10.1093.
    PubMed     Abstract available


  100. OMULO S, Ita T, Mugoh R, Ayodo C, et al
    Risk Factors for Colonization With Extended-Spectrum Cephalosporin-Resistant and Carbapenem-Resistant Enterobacterales Among Hospitalized Patients in Kenya: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available


  101. ZINO L, Wit F, Rokx C, den Hollander JG, et al
    Outcomes of bariatric surgery in people with HIV: a retrospective analysis from ATHENA cohort.
    Clin Infect Dis. 2023 Jul 1:ciad404. doi: 10.1093.
    PubMed     Abstract available


    June 2023
  102. TSCHUMI N, Lerotholi M, Motaboli L, Mokete M, et al
    Two-year outcomes of treatment-experienced adults after programmatic transitioning to dolutegravir: longitudinal data from the VICONEL HIV cohort in Lesotho.
    Clin Infect Dis. 2023 Jun 26:ciad390. doi: 10.1093.
    PubMed     Abstract available


  103. ORKIN C, Schapiro JM, Perno CF, Kuritzkes DR, et al
    Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure.
    Clin Infect Dis. 2023 Jun 21:ciad370. doi: 10.1093.
    PubMed     Abstract available


  104. WEST E, Zeeb M, Grube C, Kuster H, et al
    Sustained viral suppression with dolutegravir monotherapy over 192 weeks in patients starting combination antiretroviral therapy during primary HIV infection (EARLY-SIMPLIFIED): a randomized, controlled, multi-site, non-inferiority trial.
    Clin Infect Dis. 2023 Jun 20:ciad366. doi: 10.1093.
    PubMed     Abstract available


  105. BILSEN MP, Aantjes MJ, van Andel E, Stalenhoef JE, et al
    Current Pyuria Cutoffs Promote Inappropriate Urinary Tract Infection Diagnosis in Older Women.
    Clin Infect Dis. 2023;76:2070-2076.
    PubMed     Abstract available


  106. IWASE SC, Edlefsen PT, Bhebhe L, Motsumi K, et al
    T-SPOT.TB reactivity in Southern African children with and without in utero HIV exposure.
    Clin Infect Dis. 2023 Jun 9:ciad356. doi: 10.1093.
    PubMed     Abstract available


  107. GOTTLIEB GS
    Dolutegravir-based antiretroviral therapy for HIV-2 infection: Progress for People Living with HIV-2.
    Clin Infect Dis. 2023 Jun 8:ciad340. doi: 10.1093.
    PubMed    


  108. PACHECO P, Marques N, Rodrigues P, Mansinho K, et al
    Safety and Efficacy of Triple Therapy with Dolutegravir plus Two NRTIs, in Treatment-Naive HIV-2 Patients - Results from a 48-week Phase II Study.
    Clin Infect Dis. 2023 Jun 8:ciad339. doi: 10.1093.
    PubMed     Abstract available


  109. KILEEL EM, Malvestutto CD, Lo J, Fitch KV, et al
    Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE).
    Clin Infect Dis. 2023;76:2010-2013.
    PubMed     Abstract available


  110. BEVERS L, Waalewijn H, Szubert A, Chabala C, et al
    Pharmacokinetic data of dolutegravir in second-line treatment of children living with HIV: results from the CHAPAS4-trial.
    Clin Infect Dis. 2023 Jun 6:ciad346. doi: 10.1093.
    PubMed     Abstract available


  111. EBENUWA I, Violet PC, Michel K, Padayatty SJ, et al
    Vitamin C urinary loss and deficiency in HIV: Cross-sectional study of vitamin C renal leak in women with HIV.
    Clin Infect Dis. 2023 Jun 2:ciad333. doi: 10.1093.
    PubMed     Abstract available


    May 2023
  112. ZEEB M, Tepekule B, Kusejko K, Reiber C, et al
    Understanding the decline of incident, active tuberculosis in people with HIV in Switzerland.
    Clin Infect Dis. 2023 May 31:ciad330. doi: 10.1093.
    PubMed     Abstract available


  113. LO CKL, Komorowski AS, Hall CW, Sandstrom TS, et al
    Methodological and reporting quality of non-inferiority randomised controlled trials comparing antiretroviral therapies: a systematic review.
    Clin Infect Dis. 2023 May 27:ciad308. doi: 10.1093.
    PubMed     Abstract available


  114. SRINIVASA S, Walpert AR, Thomas TS, Huck DM, et al
    Randomized Placebo Controlled Trial to Evaluate Effects of Eplerenone on Myocardial Perfusion and Function among Persons with HIV-Results from the MIRACLE HIV Study.
    Clin Infect Dis. 2023 May 27:ciad310. doi: 10.1093.
    PubMed     Abstract available


  115. COUSSEMENT J, Heath CH, Roberts MB, Lane RJ, et al
    Current epidemiology and clinical features of Cryptococcus infection in patients without HIV infection: a multicentre study in 46 hospitals from Australia and New Zealand.
    Clin Infect Dis. 2023 May 26:ciad321. doi: 10.1093.
    PubMed     Abstract available


  116. AHSBERG J, Puplampu P, Kwashie A, Commey JO, et al
    Point-of-care urine LAM testing to guide tuberculosis treatment among severely ill in-patients with HIV in real-world practice: a multi-center stepped wedge cluster-randomized trial from Ghana.
    Clin Infect Dis. 2023 May 26:ciad316. doi: 10.1093.
    PubMed     Abstract available


  117. PASQUALOTTO AC, Dalla Lana D, Godoy CSM, Leitao TDMJS, et al
    Single High-dose of Liposomal Amphotericin B in HIV/AIDS-related Disseminated Histoplasmosis: a Randomized Trial.
    Clin Infect Dis. 2023 May 26:ciad313. doi: 10.1093.
    PubMed     Abstract available


  118. ASTURIAS EJ, Excler JL, Ackland J, Cavaleri M, et al
    Safety of Streptococcus pyogenes vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post Marketing Monitoring.
    Clin Infect Dis. 2023 May 26:ciad311. doi: 10.1093.
    PubMed     Abstract available


  119. LABHARDT ND, Brown JA, Sass N, Ford N, et al
    Treatment outcomes after offering same-day initiation of HIV treatment - how to interpret discrepancies between different studies?
    Clin Infect Dis. 2023 May 25:ciad317. doi: 10.1093.
    PubMed     Abstract available


  120. KRISHNAN S, Wu X, Kim S, McIntire K, et al
    One-year incidence of tuberculosis infection and disease among household contacts of rifampin- and multi-drug resistant tuberculosis.
    Clin Infect Dis. 2023 May 25:ciad301. doi: 10.1093.
    PubMed     Abstract available


  121. DEL AMO J
    Question of Whether Tenofovir Disoproxil Fumarate/Emtricitabine Provides Protection Against Clinical Severity of Coronavirus Disease 2019.
    Clin Infect Dis. 2023;76:1735-1737.
    PubMed    


  122. PARCZEWSKI M, Jablonowska E, Wojcik-Cichy K, Zhyvytsia D, et al
    Clinical Perspective on Human Immunodeficiency Virus Care of Ukrainian War Refugees in Poland.
    Clin Infect Dis. 2023;76:1708-1715.
    PubMed     Abstract available


  123. SEMPERE A, Assoumou L, Gonzalez-Cordon A, Waters L, et al
    Incidence of hypertension and blood pressure changes in persons with HIV at high risk for cardiovascular disease switching from boosted protease inhibitors to dolutegravir: a post-hoc analysis of the 96-week randomised NEAT-022 trial.
    Clin Infect Dis. 2023 May 19:ciad297. doi: 10.1093.
    PubMed     Abstract available


  124. WOOD BR
    Reassuring data for cardiovascular health after switching a boosted protease inhibitor to dolutegravir.
    Clin Infect Dis. 2023 May 19:ciad298. doi: 10.1093.
    PubMed    


  125. LETENDRE SL, Chen H, McKhann A, Roa J, et al
    Antiretroviral Therapy Intensification for Neurocognitive Impairment in HIV.
    Clin Infect Dis. 2023 May 15:ciad265. doi: 10.1093.
    PubMed     Abstract available


  126. GUDIPATI S, Shallal A, Peterson E, Cook B, et al
    Increase in False Positive Fourth Generation HIV Tests in Patients with COVID-19 Disease.
    Clin Infect Dis. 2023 May 9:ciad264. doi: 10.1093.
    PubMed     Abstract available


  127. SURIAL B, Chammartin F, Damas J, Calmy A, et al
    Impact of integrase inhibitors on cardiovascular disease events in people with HIV starting antiretroviral therapy.
    Clin Infect Dis. 2023 May 9:ciad286. doi: 10.1093.
    PubMed     Abstract available


  128. ANDO N, Mizushima D, Omata K, Nemoto T, et al
    Combination of Amoxicillin 3,000 mg and Probenecid versus 1,500 mg Amoxicillin Monotherapy for Treating Syphilis in Patients with HIV: an Open-Label, Randomized, Controlled, Non-Inferiority Trial.
    Clin Infect Dis. 2023 May 9:ciad278. doi: 10.1093.
    PubMed     Abstract available


  129. WAALEWIJN H, Szubert AJ, Wasmann RE, Wiesner L, et al
    First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.
    Clin Infect Dis. 2023 May 9:ciad267. doi: 10.1093.
    PubMed     Abstract available


  130. ROMANOWSKI K, Law MR, Karim ME, Campbell JR, et al
    Healthcare utilization after respiratory tuberculosis: a controlled interrupted time series analysis.
    Clin Infect Dis. 2023 May 9:ciad290. doi: 10.1093.
    PubMed     Abstract available


  131. LLIBRE JM, Kuritzkes DAR
    Long-Acting Cabotegravir and Rilpivirine: Innovation, New Challenges, and Opportunities.
    Clin Infect Dis. 2023;76:1655-1657.
    PubMed    


  132. MDINGI MM, Peters RPH, Gigi R, Babalola C, et al
    Same-Day Treatment Following Point-of-Care Sexually Transmitted Infection Testing in Different Healthcare Settings in South Africa.
    Clin Infect Dis. 2023;76:1699-1700.
    PubMed    


    April 2023
  133. BURKE RM, Nliwasa M, Dodd PJ, Feasey HR, et al
    Impact of community-wide tuberculosis active case finding and HIV testing on tuberculosis trends in Malawi.
    Clin Infect Dis. 2023 Apr 26:ciad238. doi: 10.1093.
    PubMed     Abstract available


  134. CHAISSON LH
    Finding tuberculosis: More evidence for community-wide systematic screening.
    Clin Infect Dis. 2023 Apr 26:ciad232. doi: 10.1093.
    PubMed    


  135. LEVISON J, McKinney J, Duque A, Hawkins J, et al
    Breastfeeding among people with HIV in North America: a multisite study.
    Clin Infect Dis. 2023 Apr 20:ciad235. doi: 10.1093.
    PubMed     Abstract available


  136. GLEESON SE, Zapata H, Bathgate ME, Emu B, et al
    Building an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and Reflections.
    Clin Infect Dis. 2023 Apr 20:ciad236. doi: 10.1093.
    PubMed     Abstract available


  137. SWINDELLS S, Eschenauer GA, Nason M, Daar ES, et al
    Letter to the Editor.
    Clin Infect Dis. 2023 Apr 19:ciad229. doi: 10.1093.
    PubMed    


  138. HAZRA A, Cherabie JN
    Is Mpox a Sexually Transmitted Infection? Why Narrowing the Scope of This Disease May Be Harmful.
    Clin Infect Dis. 2023;76:1504-1507.
    PubMed     Abstract available


  139. VERDECIA JL, Vootukuri SR, Sands ML, Isache CL, et al
    A Case of Necrotizing Finger Lesions in a Patient With AIDS.
    Clin Infect Dis. 2023;76:1513-1515.
    PubMed    


  140. LAURENT C, Yaya I, Cuer B, Sagaon-Teyssier L, et al
    HIV seroconversion among men who have sex with men who use event-driven or daily oral pre-exposure prophylaxis (CohMSM-PrEP): A multi-country demonstration study from West Africa.
    Clin Infect Dis. 2023 Apr 13:ciad221. doi: 10.1093.
    PubMed     Abstract available


  141. ALVAREZ H, Mocroft A, Ryom L, Neesgaard B, et al
    Plasma HIV-1 RNA and CD4+ T-cell counts are determinants of virological non-suppression outcomes with initial integrase inhibitor-based regimens: A prospective RESPOND cohort study.
    Clin Infect Dis. 2023 Apr 13:ciad219. doi: 10.1093.
    PubMed     Abstract available


  142. SABET N, Omar T, Milovanovic M, Magajane T, et al
    Undiagnosed pulmonary TB and COVID in adults dying at home in a high TB burden setting, before and during pandemic COVID-19: an autopsy study.
    Clin Infect Dis. 2023 Apr 12:ciad212. doi: 10.1093.
    PubMed     Abstract available


  143. CHEN GJ, Sun HY, Lin KY, Hsieh SM, et al
    A randomized clinical trial of one-dose versus accelerated two-dose schedule for hepatitis A virus revaccination among people with HIV who were non-responders or had seroreversion after primary HAV vaccination.
    Clin Infect Dis. 2023 Apr 10:ciad206. doi: 10.1093.
    PubMed     Abstract available


  144. BRANCHE AR, Rouphael NG, Losada C, Baden LR, et al
    Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial.
    Clin Infect Dis. 2023 Apr 10:ciad209. doi: 10.1093.
    PubMed     Abstract available


  145. EDMONDS A, Haley DF, Edwards JK, Ramirez C, et al
    Health Insurance and Initiation of Direct-Acting Antivirals for Hepatitis C in US Women with HIV.
    Clin Infect Dis. 2023 Apr 6:ciad204. doi: 10.1093.
    PubMed     Abstract available


  146. DOMBROWSKI JC, Ramchandani MS, Golden MR
    Implementation of Low-Barrier HIV Care: Lessons Learned from the Max Clinic in Seattle.
    Clin Infect Dis. 2023 Apr 6:ciad202. doi: 10.1093.
    PubMed     Abstract available


  147. DESHMUKH AA, Damgacioglu H, Georges D, Sonawane K, et al
    Human papillomavirus-associated anal cancer incidence and burden among US men, according to sexual orientation, HIV status, and age.
    Clin Infect Dis. 2023 Apr 5:ciad205. doi: 10.1093.
    PubMed     Abstract available


  148. MARKS KM, Kang M, Umbleja T, Avihingsanon A, et al
    Immunogenicity and Safety of Hepatitis B vaccine with a Toll-like Receptor 9 Agonist Adjuvant (HEPLISAV-B) in HBV Vaccine-naive People with HIV.
    Clin Infect Dis. 2023 Apr 5:ciad201. doi: 10.1093.
    PubMed     Abstract available


  149. SAUCEDA JA, Lisha NE, Ludwig-Barron N, Salazar J, et al
    The Brief HIV Index: A rapid 3-item scale to measure engagement in HIV care.
    Clin Infect Dis. 2023 Apr 5:ciad200. doi: 10.1093.
    PubMed     Abstract available


  150. SEBASTIANI G, Milic J, Kablawi D, Gioe' C, et al
    Fibroscan-aspartate aminotransferase (FAST) score predicts liver-related outcomes, but not extra-hepatic events, in a multicenter cohort of people with HIV.
    Clin Infect Dis. 2023 Apr 4:ciad203. doi: 10.1093.
    PubMed     Abstract available


  151. FUNDERBURG NT, Shive CL, Chen Z, Tatsuoka C, et al
    IL-6 blockade with tocilizumab diminishes indices of inflammation that are linked to mortality in treated HIV infection.
    Clin Infect Dis. 2023 Apr 3:ciad199. doi: 10.1093.
    PubMed     Abstract available


  152. HARVEY L, Kimmel SD, Edelman EJ
    Meeting the Moment: More Infectious Disease Physicians Must Be Prepared to Provide Buprenorphine.
    Clin Infect Dis. 2023;76:1205-1208.
    PubMed    


  153. BETTONTE S, Berton M, Stader F, Battegay M, et al
    Management of Drug-Drug Interactions Between Long-Acting Cabotegravir and Rilpivirine and Comedications With Inducing Properties: A Modeling Study.
    Clin Infect Dis. 2023;76:1225-1236.
    PubMed     Abstract available


    March 2023
  154. PEREZ MOLINA JA, Crespillo-Andujar C, Zamora J, Fernandez-Felix BM, et al
    Contribution of low CD4 cell counts and high HIV viral load to the efficacy of preferred first-line antiretroviral regimens for treating HIV infection: A systematic review and meta-analysis.
    Clin Infect Dis. 2023 Mar 28:ciad177. doi: 10.1093.
    PubMed     Abstract available


  155. ZUGER A
    Home HIV testing.
    Clin Infect Dis. 2023 Mar 28:ciad171. doi: 10.1093.
    PubMed    


  156. ABELMAN RA, Nguyen TTJ, Ma Y, Bacchetti P, et al
    Body Composition Changes over the Menopausal Transition in Women With and Without HIV.
    Clin Infect Dis. 2023 Mar 28:ciad165. doi: 10.1093.
    PubMed     Abstract available


  157. XIE L, Li W, Ye WM, Xiao Y, et al
    Serum ubiquitin C-terminal hydrolase-L1, glial fibrillary acidic protein, and neurofilament light chain are good entry points and biomarker candidates for neurosyphilis diagnosis among patients without HIV to avoid lumbar puncture.
    Clin Infect Dis. 2023 Mar 17:ciad158. doi: 10.1093.
    PubMed     Abstract available


  158. LEWER D, Brothers TD, Croxford S, Desai M, et al
    Opioid injection-associated bacterial infections in England, 2002-2021: a time series analysis of seasonal variation and the impact of COVID-19.
    Clin Infect Dis. 2023 Mar 14:ciad144. doi: 10.1093.
    PubMed     Abstract available


  159. MUSUMECI S, Najjar I, Boffi El Amari E, Schibler M, et al
    A case of mpox reinfection.
    Clin Infect Dis. 2023 Mar 11:ciad147. doi: 10.1093.
    PubMed     Abstract available


  160. PARCZEWSKI M, Jablonowska E, Wojcik-Cichy K, Zhyvytsia D, et al
    Clinical perspective on HIV care of Ukrainian war refugees in Poland.
    Clin Infect Dis. 2023 Mar 8:ciad116. doi: 10.1093.
    PubMed     Abstract available


  161. BOULWARE DR, Jarvis JN
    Timing of antiretroviral therapy in cryptococcal meningitis: What we can (and cannot) learn from observational data.
    Clin Infect Dis. 2023 Mar 8:ciad123. doi: 10.1093.
    PubMed    


  162. RON R, Moreno E, Martinez-Sanz J, Branas F, et al
    CD4/CD8 ratio during HIV treatment: time for routine monitoring?
    Clin Infect Dis. 2023 Mar 8:ciad136. doi: 10.1093.
    PubMed     Abstract available


  163. INGLE SM, Miro JM, May MT, Cain LE, et al
    Early antiretroviral therapy not associated with higher cryptococcal meningitis mortality in people with HIV in high-income countries: an international collaborative cohort study.
    Clin Infect Dis. 2023 Mar 8:ciad122. doi: 10.1093.
    PubMed     Abstract available


  164. BONNET M, Gabillard D, Domoua S, Muzoora C, et al
    High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF(R) for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV.
    Clin Infect Dis. 2023 Mar 8:ciad125. doi: 10.1093.
    PubMed     Abstract available


  165. FRELING S, Wald-Dickler N, Banerjee J, Canamar CP, et al
    Real-world Application of Oral Therapy for Infective Endocarditis: A Multicenter Retrospective, Cohort Study.
    Clin Infect Dis. 2023 Mar 7:ciad119. doi: 10.1093.
    PubMed     Abstract available


  166. LEA AN, Leyden WA, Sofrygin O, Marafino BJ, et al
    Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 (COVID-19) Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.
    Clin Infect Dis. 2023 Mar 2:ciad084. doi: 10.1093.
    PubMed     Abstract available


  167. DEL AMO J
    Question of Whether Tenofovir Disoproxil Fumarate/Emtricitabine Provides Protection Against Clinical Severity of Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2023 Mar 2:ciad086. doi: 10.1093.
    PubMed    


  168. IMP BM, Levine T, Satre DD, Skarbinski J, et al
    Influenza Vaccination Uptake and Associated Factors Among Adults With and Without HIV in a Large, Integrated Health Care System.
    Clin Infect Dis. 2023 Mar 1:ciad106. doi: 10.1093.
    PubMed     Abstract available


    February 2023
  169. SCHAPIRO JM
    Dynamics of HIV-1 A6 variant transmissions between Poland and Ukraine.
    Clin Infect Dis. 2023 Feb 28:ciad062. doi: 10.1093.
    PubMed    


  170. SERWIN K, Chaillon A, Schiebe K, Urbanska A, et al
    Circulation of HIV-1 A6 variant in the East border of European Union - dynamics of the virus transmissions between Poland and Ukraine.
    Clin Infect Dis. 2023 Feb 28:ciad058. doi: 10.1093.
    PubMed     Abstract available


  171. PERSON AK, Ramirez BC, Kim A, Veloso V, et al
    Cryptococcal Meningitis and Clinical Outcomes in Persons with HIV: A Global View.
    Clin Infect Dis. 2023 Feb 23:ciad076. doi: 10.1093.
    PubMed     Abstract available


  172. NOSYK B, Fojo AT, Kasaie P, Enns B, et al
    The testing imperative: Why the US EHE needs to renew efforts to expand HIV testing in clinical and community-based settings.
    Clin Infect Dis. 2023 Feb 23:ciad103. doi: 10.1093.
    PubMed     Abstract available


  173. SADOWSKI C, Belknap R, Holland DP, Moro RN, et al
    Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection.
    Clin Infect Dis. 2023 Feb 23:ciad083. doi: 10.1093.
    PubMed     Abstract available


  174. NALINTYA E, Sekar P, Kavuma P, Kigozi J, et al
    Effect of Covid-19 lockdowns on identification of advanced HIV disease in outpatient clinics in Uganda.
    Clin Infect Dis. 2023 Feb 17:ciad087. doi: 10.1093.
    PubMed     Abstract available


  175. GONSALVES GS, Paltiel AD, Thornhill T, DeMaria A, et al
    Patterns of Infectious Disease Associated with Injection Drug Use in Massachusetts.
    Clin Infect Dis. 2023 Feb 9:ciad073. doi: 10.1093.
    PubMed     Abstract available


  176. HIGGINS DM, Moore M, Alderton L, Weinberg L, et al
    Evaluation of a statewide online at-home STI and HIV screening program.
    Clin Infect Dis. 2023 Feb 9:ciad071. doi: 10.1093.
    PubMed     Abstract available


  177. CROCKETT KB, Schember CO, Bian A, Rebeiro PF, et al
    Relationships between Patient Race and Residential Race Context with Missed HIV Care Visits in the United States, 2010-2015.
    Clin Infect Dis. 2023 Feb 9:ciad069. doi: 10.1093.
    PubMed     Abstract available


  178. SHIN A, Ritchie SR, Billington KA, Hallot CJ, et al
    Subacute Left Leg Pain in a 48-Year-Old Man Living With Human Immunodeficiency Virus and a Previous History of Plasmablastic Lymphoma.
    Clin Infect Dis. 2023;76:550-553.
    PubMed    


  179. MEJIA-CHEW C, Carver PL, Rutjanawech S, Camargo LFA, et al
    Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study.
    Clin Infect Dis. 2023;76:e995-e1003.
    PubMed     Abstract available


  180. BLOCH EM, Focosi D, Shoham S, Senefeld J, et al
    Guidance on the use of convalescent plasma to treat immunocompromised patients with COVID-19.
    Clin Infect Dis. 2023 Feb 6:ciad066. doi: 10.1093.
    PubMed     Abstract available


  181. OLIVER SE, Rubis AB, Soeters HM, Reingold A, et al
    Epidemiology of invasive nontypeable Haemophilus influenzae disease-United States, 2008-2019.
    Clin Infect Dis. 2023 Feb 1:ciad054. doi: 10.1093.
    PubMed     Abstract available


  182. SANGARE MN, Baril JG, de Pokomandy A, Klein M, et al
    CD4/CD8 ratio outcome according to the class of the third active drug in antiretroviral therapy (ART) regimens: results from the Quebec Human Immunodeficiency Virus (HIV) Cohort Study.
    Clin Infect Dis. 2023 Feb 1:ciad056. doi: 10.1093.
    PubMed     Abstract available


    January 2023
  183. PAULSEN FW, Tetens MM, Vollmond CV, Gerstoft J, et al
    Incidence of childbirth, pregnancy, spontaneous abortion, and induced abortion among women with Human Immunodeficiency Virus (HIV), a nationwide matched cohort study.
    Clin Infect Dis. 2023 Jan 31:ciad053. doi: 10.1093.
    PubMed     Abstract available


  184. GOVIND A, Lazarte SM, Kitchell E, Chow JY, et al
    Severe Mpox Infections in People with Uncontrolled Human Immunodeficiency Virus (HIV).
    Clin Infect Dis. 2023 Jan 31:ciad052. doi: 10.1093.
    PubMed     Abstract available


  185. MOLLDREM S
    Research on the Development of SARS-CoV-2 Variants of Concern in People with Advanced HIV Disease Should Highlight Structural Conditions and Avoid Harmful Stereotypes.
    Clin Infect Dis. 2023 Jan 31:ciad048. doi: 10.1093.
    PubMed    



  186. Correction to: Principles for Ending Human Immunodeficiency Virus as an Epidemic in the United States: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.
    Clin Infect Dis. 2023 Jan 24:ciad028. doi: 10.1093.
    PubMed    


  187. SOWAH LA, Smeaton L, Brates I, Bhattacharya D, et al
    Perspectives on Adherence from the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach with 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment.
    Clin Infect Dis. 2023 Jan 24:ciad034. doi: 10.1093.
    PubMed     Abstract available


  188. AVERY EF, Kleynhans JN, Ledergerber B, Schoepf IC, et al
    Leukocyte Count and Coronary Artery Disease Events in People with HIV: A Longitudinal Study.
    Clin Infect Dis. 2023 Jan 23:ciad033. doi: 10.1093.
    PubMed     Abstract available


  189. ORTIZ-BRIZUELA E, Apriani L, Mukherjee T, Lachapelle-Chisholm S, et al
    Assessing the diagnostic performance of new commercial IGRAs for Mycobacterium tuberculosis infection: a systematic review and meta-analysis.
    Clin Infect Dis. 2023 Jan 23:ciad030. doi: 10.1093.
    PubMed     Abstract available


  190. OVERTON ET, Richmond G, Rizzardini G, Thalme A, et al
    Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection: 152-week results from ATLAS-2M, a randomized, open-label, Phase 3b, noninferiority study.
    Clin Infect Dis. 2023 Jan 20:ciad020. doi: 10.1093.
    PubMed     Abstract available


  191. WOOD BR, Stekler JD
    Could home HIV self-testing ever become a game changer?
    Clin Infect Dis. 2023 Jan 16:ciad026. doi: 10.1093.
    PubMed     Abstract available


  192. ZHAO Y, Griesel R, Omar Z, Simmons B, et al
    Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: a non-comparative, double-blind, randomised placebo-controlled trial.
    Clin Infect Dis. 2023 Jan 16:ciad023. doi: 10.1093.
    PubMed     Abstract available


  193. MA S, MacGowan RJ, Mermin JH, Owen SM, et al
    Accelerating HIV Self-Testing in the United States: A Call to Action.
    Clin Infect Dis. 2023 Jan 16:ciad025. doi: 10.1093.
    PubMed     Abstract available


  194. ANDERSON PL, Marzinke MA, Glidden DV
    Updating the adherence-response for oral F-TDF for PrEP among cisgender women.
    Clin Infect Dis. 2023 Jan 16:ciad021. doi: 10.1093.
    PubMed     Abstract available


  195. LEVI LI, Molina JM
    Cytomegalovirus (CMV) viremia in people with Human Immunodeficiency Virus (HIV): should we treat the CMV? Or the HIV? or Both?
    Clin Infect Dis. 2023 Jan 10:ciad011. doi: 10.1093.
    PubMed    


  196. DEDRICK RM, Smith BE, Cristinziano M, Freeman KG, et al
    Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease.
    Clin Infect Dis. 2023;76:103-112.
    PubMed     Abstract available


  197. COOLEY SA, Nelson B, Boerwinkle A, Yarasheski KE, et al
    Plasma Abeta42/Abeta40 ratios are not reduced in older people living with HIV.
    Clin Infect Dis. 2023 Jan 5:ciad001. doi: 10.1093.
    PubMed     Abstract available


  198. BERHANU RH, Lebina L, Nonyane BAS, Milovanovic M, et al
    Yield of facility-based targeted universal testing for tuberculosis (TUTT) with Xpert and mycobacterial culture in high-risk groups attending primary care facilities in South Africa.
    Clin Infect Dis. 2023 Jan 5:ciac965. doi: 10.1093.
    PubMed     Abstract available


  199. BLANC P, Bonnet F, Leleux O, Perrier A, et al
    Severe bacterial non-AIDS infections in persons with HIV: the epidemiology and evolution of antibiotic resistance over an 18-year period (2000-2017) in the ANRS CO3 AquiVih-Nouvelle-Aquitaine cohort.
    Clin Infect Dis. 2023 Jan 4:ciac978. doi: 10.1093.
    PubMed     Abstract available


  200. SOLANS BP, Beranger A, Radtke K, Mohamed A, et al
    Effectiveness and pharmacokinetic exposures of first-line drugs used to treat drug-susceptible tuberculosis in children: a systematic review and meta-analysis.
    Clin Infect Dis. 2023 Jan 4:ciac973. doi: 10.1093.
    PubMed     Abstract available


  201. AHRENS K, Sharbaugh M, Jarlenski MP, Tang L, et al
    Prevalence of testing for HIV, HBV, and HCV among Medicaid enrollees treated with medications for opioid use disorder in 11 states, 2016-2019.
    Clin Infect Dis. 2023 Jan 3:ciac981. doi: 10.1093.
    PubMed     Abstract available


    December 2022
  202. FANG MZ, Jackson SS, Pfeiffer RM, Kim EY, et al
    No Association of IFNL4 Genotype With Opportunistic Infections and Cancers Among Men With Human Immunodeficiency Virus 1 Infection.
    Clin Infect Dis. 2022 Dec 27:ciac447. doi: 10.1093.
    PubMed     Abstract available


  203. THET AK, Kelly PJ, Kasule SN, Shah AK, et al
    The use of vaccinia immune globulin in the treatment of severe mpox virus infection in HIV/AIDS.
    Clin Infect Dis. 2022 Dec 26:ciac971. doi: 10.1093.
    PubMed     Abstract available


  204. DE SALAZAR A, Vinuela L, Fuentes A, Teyssou E, et al
    Transmitted drug resistance to integrase based first-line HIV antiretroviral regimens in the Mediterranean Europe.
    Clin Infect Dis. 2022 Dec 26:ciac972. doi: 10.1093.
    PubMed     Abstract available


  205. ALLAN-BLITZ LT, Gandhi M, Adamson P, Park I, et al
    A Position Statement on Mpox as a Sexually Transmitted Disease.
    Clin Infect Dis. 2022 Dec 22:ciac960. doi: 10.1093.
    PubMed     Abstract available


  206. CHOUFANY M, Weiss L, Makinson A, Roul H, et al
    Decrease in CD4 count and risk of severe morbidity in PWH with controlled viral load after initiating cART between 2006 and 2018.
    Clin Infect Dis. 2022 Dec 17:ciac939. doi: 10.1093.
    PubMed     Abstract available


  207. SALAHUDDIN S, Cohen O, Wu M, Perez Irizarry J, et al
    HIV is associated with poor overall survival among head and neck cancer patients.
    Clin Infect Dis. 2022 Dec 15:ciac924. doi: 10.1093.
    PubMed     Abstract available


  208. BOSCH B, Akpomiemie G, Chandiwana N, Sokhela S, et al
    Weight and metabolic changes after switching from tenofovir alafenamide (TAF)/emtricitabine (FTC)+dolutegravir (DTG), tenofovir disoproxil fumarate (TDF)/FTC+DTG and TDF/FTC/efavirenz (EFV) to TDF/lamivudine (3TC)/DTG.
    Clin Infect Dis. 2022 Dec 15:ciac949. doi: 10.1093.
    PubMed     Abstract available


  209. WANG Y, Noel-Romas L, Perner M, Knodel S, et al
    Non-Lactobacillus dominant and polymicrobial vaginal microbiomes are more common in younger South African women and predictive of increased risk of HIV acquisition.
    Clin Infect Dis. 2022 Dec 12:ciac938. doi: 10.1093.
    PubMed     Abstract available


  210. DAVIS AG, Wasserman S, Stek C, Maxebengula M, et al
    A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis (The LASER-TBM Trial).
    Clin Infect Dis. 2022 Dec 9:ciac932. doi: 10.1093.
    PubMed     Abstract available


  211. COHEN JI, Dropulic L, Wang K, Gangler K, et al
    Comparison of levels of nasal, salivary, and plasma antibody to SARS-CoV-2 during natural infection and after vaccination.
    Clin Infect Dis. 2022 Dec 9:ciac934. doi: 10.1093.
    PubMed     Abstract available


  212. POLITI J, Regidor E, Donat M, Pulido J, et al
    Free access to direct-acting antivirals in Spain: more favorable impact on hepatitis C mortality among highly educated people.
    Clin Infect Dis. 2022 Dec 6:ciac928. doi: 10.1093.
    PubMed     Abstract available


  213. RUFFIEUX Y, Muchengeti M, Olago V, Dhokotera T, et al
    Age and cancer incidence in 5.2 million people with HIV: the South African HIV Cancer Match study.
    Clin Infect Dis. 2022 Dec 3:ciac925. doi: 10.1093.
    PubMed     Abstract available


  214. HANRAHAN CF, Nonyane BAS, Lebina L, Mmolawa L, et al
    Household versus incentive-based contact investigation for tuberculosis in rural South Africa: a cluster-randomized trial.
    Clin Infect Dis. 2022 Dec 2:ciac920. doi: 10.1093.
    PubMed     Abstract available


  215. JASSAT W, Abdool Karim SS, Ozougwu L, Welch R, et al
    Trends in Cases, Hospitalization and Mortality Related to the Omicron BA.4/BA.5 Sub-Variants in South Africa.
    Clin Infect Dis. 2022 Dec 1:ciac921. doi: 10.1093.
    PubMed     Abstract available


    November 2022
  216. YAN J, Steiger SN, Kodama R, Fender J, et al
    Predictors of COVID-19 hospitalization after sotrovimab in hematologic malignancy patients during the BA.1 Omicron surge.
    Clin Infect Dis. 2022 Nov 29:ciac916. doi: 10.1093.
    PubMed     Abstract available


  217. MOKHTAR S, Parpia AS, Lo NC, Ndeffo-Mbah ML, et al
    Evaluation of the United States definitions for COVID-19 community risk levels.
    Clin Infect Dis. 2022 Nov 26:ciac922. doi: 10.1093.
    PubMed     Abstract available


  218. FLEXNER C, Siccardi M, Bunglawala F, Owen A, et al
    The LEAP Process: Streamlining the Development of Long-Acting Products and Formulations for Infectious Diseases.
    Clin Infect Dis. 2022;75.
    PubMed     Abstract available


  219. THOMAS DL, Kiser JJ, Baum MM
    Long-Acting Treatments for Hepatitis B.
    Clin Infect Dis. 2022;75.
    PubMed     Abstract available


  220. CASKEY M, Kuritzkes DR
    Monoclonal Antibodies as Long-Acting Products: What Are We Learning From Human Immunodeficiency Virus (HIV) and Coronavirus Disease 2019 (COVID-19)?
    Clin Infect Dis. 2022;75.
    PubMed     Abstract available


  221. NEARY M, Owen A, Olagunju A
    A Holistic Review of the Preclinical Landscape for Long-Acting Anti-infective Drugs Using HIV as a Paradigm.
    Clin Infect Dis. 2022;75.
    PubMed     Abstract available


  222. COOPER SE, Rosenblatt J, Gulick RM
    Barriers to Uptake of Long-Acting Antiretroviral Products for Treatment and Prevention of Human Immunodeficiency Virus (HIV) in High-Income Countries.
    Clin Infect Dis. 2022;75.
    PubMed     Abstract available


  223. OLAGUNJU A, Mathad J, Eke A, Delaney-Moretlwe S, et al
    Considerations for the Use of Long-Acting and Extended-Release Agents During Pregnancy and Lactation.
    Clin Infect Dis. 2022;75.
    PubMed     Abstract available


  224. FLEXNER C, Thomas DL, Clayden P, Swindells S, et al
    What Clinicians Need to Know About the Development of Long-Acting Formulations.
    Clin Infect Dis. 2022;75.
    PubMed    


  225. ABRAMS EJ, Capparelli E, Ruel T, Mirochnick M, et al
    Potential of Long-Acting Products to Transform the Treatment and Prevention of Human Immunodeficiency Virus (HIV) in Infants, Children, and Adolescents.
    Clin Infect Dis. 2022;75.
    PubMed     Abstract available


  226. BROWN RIPIN DH, Catlin K, Lewis L, Resar D, et al
    Transitioning Long-Acting Products to a Generic Marketplace: What's Missing?
    Clin Infect Dis. 2022;75.
    PubMed     Abstract available


  227. ARYA V, Hodowanec AC, Troy SB, Struble KA, et al
    Long-Acting Formulations for the Prevention and Treatment of Human Immunodeficiency Virus (HIV)-1 Infection: Strategic Leveraging and Integration of Multidisciplinary Knowledge to Advance Public Health.
    Clin Infect Dis. 2022;75.
    PubMed     Abstract available


  228. KITYO C, Cortes CP, Phanuphak N, Grinsztejn B, et al
    Barriers to Uptake of Long-Acting Antiretroviral Products for Treatment and Prevention of HIV in Low- and Middle-Income Countries (LMICs).
    Clin Infect Dis. 2022;75.
    PubMed     Abstract available


  229. HUSSEN SA, Doraivelu K, Goldstein MH, Shenvi N, et al
    HIV Care Continuum Outcomes After Transition to Adult Care among a Prospective Cohort of Youth with HIV in Atlanta, Georgia.
    Clin Infect Dis. 2022 Nov 21:ciac904. doi: 10.1093.
    PubMed     Abstract available


  230. FINELLI PF
    New Onset Focal Tremor in Patient With Human Immunodeficiency Virus.
    Clin Infect Dis. 2022;75:1861-1863.
    PubMed    


  231. FANG M, Lin X, Wang C, Yang X, et al
    High cytomegalovirus viral load is associated with 182-day all-cause mortality in hospitalized people with human immunodeficiency virus (PWH).
    Clin Infect Dis. 2022 Nov 14. pii: 6827090. doi: 10.1093.
    PubMed     Abstract available


  232. RUFFIN F, Dagher M, Park LP, Wanda L, et al
    Black and White Patients with Staphylococcus aureus Bacteremia have Similar Outcomes but Different Risk Factors.
    Clin Infect Dis. 2022 Nov 14. pii: 6826998. doi: 10.1093.
    PubMed     Abstract available


  233. VINK FJ, Meijer CJLM, Lissenberg-Witte BI, Visser C, et al
    Validation of ASCL1 and LHX8 Methylation Analysis as Primary Cervical Cancer Screening Strategy in South African Women with Human Immunodeficiency Virus.
    Clin Infect Dis. 2022 Nov 11. pii: 6822465. doi: 10.1093.
    PubMed     Abstract available


  234. HENRARD S, Trotta N, Rovai A, Coolen T, et al
    Impact of HIV and recreational drugs on cognitive functions.
    Clin Infect Dis. 2022 Nov 11. pii: 6821337. doi: 10.1093.
    PubMed     Abstract available


  235. TURCOTTE I, El-Far M, Sadouni M, Chartrand-Lefebvre C, et al
    Association between the development of sub-clinical cardiovascular disease and HIV reservoir markers in people with HIV on suppressive ART.
    Clin Infect Dis. 2022 Nov 8. pii: 6811511. doi: 10.1093.
    PubMed     Abstract available


  236. BERENGUER J, Jarrin I, Bellon JM, Diez C, et al
    Obesity-related SNPs and weight gain following first-line antiretroviral therapy.
    Clin Infect Dis. 2022 Nov 8. pii: 6809103. doi: 10.1093.
    PubMed     Abstract available


  237. STEYTLER J, Craig C, van der Ryst E, Van Baelen B, et al
    Characterization of Viruses in Phase III and Phase IIIb Trials (The Ring Study and DREAM) of the Dapivirine Vaginal Ring for HIV-1 Infection Risk Reduction.
    Clin Infect Dis. 2022 Nov 8. pii: 6809078. doi: 10.1093.
    PubMed     Abstract available


  238. NDEGE R, Ngome O, Vanobberghen F, Bani F, et al
    Ultrasound in managing extrapulmonary tuberculosis: A randomised, controlled, parallel, superiority, open-label trial.
    Clin Infect Dis. 2022 Nov 4. pii: 6801068. doi: 10.1093.
    PubMed     Abstract available


  239. MALANGU B, Bentil-Owusu S, Mattappallil A, Sackey J, et al
    Prolonged QTc in Black and Latinx Cisgender and Transgender Women With HIV in an Urban Area.
    Clin Infect Dis. 2022 Nov 4. pii: 6801107. doi: 10.1093.
    PubMed    


    October 2022
  240. ELLIS RJ, Chenna A, Lie Y, Curanovic D, et al
    Higher levels of cerebrospinal fluid and plasma neurofilament light in human immunodeficiency virus-associated distal sensory polyneuropathy.
    Clin Infect Dis. 2022 Oct 31. pii: 6780318. doi: 10.1093.
    PubMed     Abstract available


  241. WATERS L, de Miguel-Buckley R, Poulin S, Arribas JR, et al
    Broadly Neutralizing Antibodies for HIV Treatment: Broad in Theory, Narrow in Reality.
    Clin Infect Dis. 2022 Oct 28. pii: 6776109. doi: 10.1093.
    PubMed     Abstract available


  242. BAHR NC, Skipper CP, Huppler-Hullsiek K, Ssebambulidde K, et al
    Recurrence of symptoms following cryptococcal meningitis - characterizing a diagnostic conundrum with multiple etiologies.
    Clin Infect Dis. 2022 Oct 28. pii: 6776123. doi: 10.1093.
    PubMed     Abstract available



  243. Correction to: Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America.
    Clin Infect Dis. 2022 Oct 26. pii: 6775126. doi: 10.1093.
    PubMed    


  244. PANDEY K, Fairley CK, Chen MY, Williamson DA, et al
    Changes in the syphilis reactive plasma regain (RPR) titre between diagnosis and treatment.
    Clin Infect Dis. 2022 Oct 26. pii: 6773678. doi: 10.1093.
    PubMed     Abstract available


  245. WALSH BS, Kesselheim AS, Rome BN
    Medicaid Spending on Antiretrovirals from 2007-2019.
    Clin Infect Dis. 2022 Oct 21. pii: 6765227. doi: 10.1093.
    PubMed     Abstract available


  246. DAVIS AG, Dreyer AJ, Albertyn C, Maxebengula M, et al
    Cognitive Impairment in Tuberculous Meningitis.
    Clin Infect Dis. 2022 Oct 20. pii: 6763738. doi: 10.1093.
    PubMed     Abstract available


  247. WATERS L, Assoumou L, Gonzalez-Cordon A, Rusconi S, et al
    Limited weight impact after switching from boosted protease inhibitors to dolutegravir in persons with HIV with high cardiovascular risk: a post hoc analysis of the 96-week NEAT-022 randomized trial.
    Clin Infect Dis. 2022 Oct 19. pii: 6763268. doi: 10.1093.
    PubMed     Abstract available


  248. CLARKE KEN, Hong K, Schoonveld M, Greenspan AI, et al
    Severity of COVID-19 Hospitalization Outcomes and Patient Disposition Differ by Disability Status and Disability Type.
    Clin Infect Dis. 2022 Oct 19. pii: 6763266. doi: 10.1093.
    PubMed     Abstract available


  249. JOHNSON KA, Okochi H, Arreguin M, Watabe J, et al
    Brief Report: Urine Tenofovir Levels Strongly Correlate with Virologic Suppression in Patients with HIV on Tenofovir Alafenamide-Based Antiretroviral Therapy.
    Clin Infect Dis. 2022 Oct 18. pii: 6762398. doi: 10.1093.
    PubMed     Abstract available


  250. ASARE K, Andine T, Naicker N, Dorward J, et al
    Impact of point-of-care testing on the management of sexually transmitted infections in South Africa: Evidence from the HVTN702 HIV vaccine trial.
    Clin Infect Dis. 2022 Oct 15. pii: 6761890. doi: 10.1093.
    PubMed     Abstract available


  251. HOFMANN E, Surial B, Boillat-Blanco N, Gunthard HF, et al
    HBV REPLICATION DURING TENOFOVIR THERAPY IS FREQUENT IN HIV/HBV-COINFECTION.
    Clin Infect Dis. 2022 Oct 15. pii: 6761485. doi: 10.1093.
    PubMed     Abstract available


  252. JACOB JS, Shaikh A, Goli K, Rich NE, et al
    Improved Survival after Liver Transplantation for Patients with HIV and HIV/HCV Coinfection in the INSTI and DAA eras.
    Clin Infect Dis. 2022 Oct 12. pii: 6758523. doi: 10.1093.
    PubMed     Abstract available


  253. HEATH PT, Galiza EP, Baxter DN, Boffito M, et al
    Safety and Efficacy of the NVX-CoV2373 COVID-19 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
    Clin Infect Dis. 2022 Oct 10. pii: 6754597. doi: 10.1093.
    PubMed     Abstract available


  254. HILEMAN CO, Durieux JC, Janus SE, Bowman E, et al
    Heroin use is associated with vascular inflammation in HIV.
    Clin Infect Dis. 2022 Oct 7. pii: 6752817. doi: 10.1093.
    PubMed     Abstract available


  255. FIDLER S, Fox J, Tipoe T, Longet S, et al
    Booster vaccination against SARS-CoV-2 induces potent immune responses in people with HIV.
    Clin Infect Dis. 2022 Oct 5. pii: 6748267. doi: 10.1093.
    PubMed     Abstract available


  256. STEYTLER J, van der Ryst E, Craig C, Van Baelen B, et al
    Clinical Presentation, Treatment Response and Virology Outcomes of Women who Seroconverted in the Dapivirine Vaginal Ring Trials - The Ring Study and DREAM.
    Clin Infect Dis. 2022 Oct 3. pii: 6746730. doi: 10.1093.
    PubMed     Abstract available


  257. SHITOLE SG, Lazar JM, Taub CC, Furlani AC, et al
    HIV and Cardiac End-Organ Damage in Women: Findings from an Echocardiographic Study Across the United States.
    Clin Infect Dis. 2022 Oct 3. pii: 6746717. doi: 10.1093.
    PubMed     Abstract available


    September 2022
  258. HEWISON C, Khan U, Bastard M, Lachenal N, et al
    Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort.
    Clin Infect Dis. 2022;75:1006-1013.
    PubMed     Abstract available


  259. HARRISON TS, Lawrence DS, Mwandumba HC, Boulware DR, et al
    How applicable is the single-dose AMBITION regimen for HIV-associated cryptococcal meningitis to high-income settings?
    Clin Infect Dis. 2022 Sep 27. pii: 6724283. doi: 10.1093.
    PubMed     Abstract available


  260. HERMANS LE, Umunnakwe CN, Lalla-Edward ST, Hebel SK, et al
    Point-Of-Care Tenofovir urine Testing for the Prediction of Treatment Failure and Drug Resistance During Initial Treatment for HIV-1 Infection.
    Clin Infect Dis. 2022 Sep 22. pii: 6711553. doi: 10.1093.
    PubMed     Abstract available


  261. BURNS CM, Pung L, Witt D, Gao M, et al
    Development of an HIV Risk Prediction Model Using Electronic Health Record Data from an Academic Health System in the Southern United States.
    Clin Infect Dis. 2022 Sep 19. pii: 6705475. doi: 10.1093.
    PubMed     Abstract available


  262. IQBAL K, Dong X, Zhu W, Wiener J, et al
    Decreased HIV diagnosis rates among Black and Hispanic or Latino MSM in U.S. jurisdictions supported by the THRIVE demonstration project, 2014-2019.
    Clin Infect Dis. 2022 Sep 17. pii: 6702535. doi: 10.1093.
    PubMed     Abstract available


  263. ZANNI MV, Foldyna B, McCallum S, Burdo TH, et al
    Sex-Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation among People with HIV in the U.S.
    Clin Infect Dis. 2022 Sep 14. pii: 6697021. doi: 10.1093.
    PubMed     Abstract available


  264. ELVSTAM O, Malmborn K, Elen S, Marrone G, et al
    Virologic failure following low-level viremia and viral blips during antiretroviral therapy: results from a European multicenter cohort.
    Clin Infect Dis. 2022 Sep 14. pii: 6696999. doi: 10.1093.
    PubMed     Abstract available


  265. KAY A, Reyes JM, Devezin T, Bakaya M, et al
    Optimal timing of antiretroviral therapy initiation in children and adolescents with HIV-associated pulmonary tuberculosis.
    Clin Infect Dis. 2022 Sep 13. pii: 6696609. doi: 10.1093.
    PubMed     Abstract available


  266. MCKINNEY J, Mirani G, Levison J
    Providers have a responsibility to discuss options for infant feeding with pregnant people with HIV in high-income countries.
    Clin Infect Dis. 2022 Sep 13. pii: 6696602. doi: 10.1093.
    PubMed     Abstract available


  267. SCHOEPF IC, Thorball CW, Kovari H, Ledergerber B, et al
    Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons Living with HIV: The Swiss HIV Cohort Study.
    Clin Infect Dis. 2022 Sep 13. pii: 6696567. doi: 10.1093.
    PubMed     Abstract available


  268. ROSS J, Brazier E, Fatti G, Jaquet A, et al
    Same-day ART initiation as a predictor of loss to follow-up and viral suppression among people living with HIV in sub-Saharan Africa.
    Clin Infect Dis. 2022 Sep 13. pii: 6696598. doi: 10.1093.
    PubMed     Abstract available


  269. ALONSO-NAVARRO R, Cuesta G, Santos M, Cardozo C, et al
    Qualitative Subgenomic RNA to Monitor the Response to Remdesivir in Hospitalized Patients with COVID-19: impact on the length of hospital stay and mortality.
    Clin Infect Dis. 2022 Sep 13. pii: 6696600. doi: 10.1093.
    PubMed     Abstract available


  270. ANDAGALU B, Watson OJ, Onyango I, Opot B, et al
    Reply to Blanken et al.
    Clin Infect Dis. 2022 Sep 7. pii: 6693560. doi: 10.1093.
    PubMed    


  271. MUIRU AN, Madden E, Scherzer R, Horberg MA, et al
    Effect of adopting the new race-free 2021 CKD-EPI eGFR creatinine equation on racial differences in kidney disease progression among people with HIV; an observational study.
    Clin Infect Dis. 2022 Sep 7. pii: 6693406. doi: 10.1093.
    PubMed     Abstract available


  272. HADLEY M, Powell A
    Severely restricting abortion threatens equitable health outcomes for people living with HIV.
    Clin Infect Dis. 2022 Sep 5. pii: 6691832. doi: 10.1093.
    PubMed     Abstract available


  273. GEDELA K, Da Silva Fontoura D, Salam A, Gorman G, et al
    Infectious proctitis due to human monkeypox.
    Clin Infect Dis. 2022 Sep 2. pii: 6683843. doi: 10.1093.
    PubMed     Abstract available


  274. VAN DIJCK C, Hens N, Kenyon C, Tsoumanis A, et al
    The roles of unrecognized monkeypox cases, contact isolation and vaccination in determining epidemic size in Belgium. A modelling study.
    Clin Infect Dis. 2022 Sep 2. pii: 6686539. doi: 10.1093.
    PubMed     Abstract available


  275. SWANK Z, Senussi Y, Manickas-Hill Z, Yu XG, et al
    Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae.
    Clin Infect Dis. 2022 Sep 2. pii: 6686531. doi: 10.1093.
    PubMed     Abstract available


  276. CHEW KW, Wu K, Tassiopoulos K, Palella FJ, et al
    Liver inflammation is common and linked to metabolic derangements in persons with treated HIV.
    Clin Infect Dis. 2022 Sep 1. pii: 6682837. doi: 10.1093.
    PubMed     Abstract available


  277. ROCCO JM, Laidlaw E, Galindo F, Anderson M, et al
    Severe mycobacterial IRIS in advanced HIV has features of hemophagocytic lymphohistiocytosis and requires prolonged immune suppression.
    Clin Infect Dis. 2022 Sep 1. pii: 6681110. doi: 10.1093.
    PubMed     Abstract available


    August 2022
  278. PETTIT AC, Phillips PP, Kurbatova E, Vernon A, et al
    Rifapentine with and without moxifloxacin for pulmonary tuberculosis in people with HIV (S31/A5349).
    Clin Infect Dis. 2022 Aug 30. pii: 6679254. doi: 10.1093.
    PubMed     Abstract available


  279. SIBIUDE J, Le Chenadec J, Mandelbrot L, Hoctin A, et al
    Update of Perinatal HIV-1 Transmission in France: zero transmission for 5482 mothers on continuous ART from conception and with undetectable viral load at delivery.
    Clin Infect Dis. 2022 Aug 29. pii: 6678600. doi: 10.1093.
    PubMed     Abstract available


  280. BURRY J, Casas CP, Ford N
    Access to medicines for treating people with cryptococcal meningitis.
    Clin Infect Dis. 2022 Aug 29. pii: 6678599. doi: 10.1093.
    PubMed     Abstract available


  281. NELSON BS, Tierney C, Persaud D, Jao J, et al
    Infants Receiving Very Early ART Have High CD4 Counts in the First Year of Life.
    Clin Infect Dis. 2022 Aug 29. pii: 6678126. doi: 10.1093.
    PubMed     Abstract available


  282. DIRAJLAL-FARGO S, Zhao C, Labbato D, Sattar A, et al
    Longitudinal changes in subclinical vascular disease in Ugandan youth with HIV.
    Clin Infect Dis. 2022 Aug 25. pii: 6675220. doi: 10.1093.
    PubMed     Abstract available


  283. MONIN MB, Ingiliz P, Lutz T, Scholten S, et al
    Low spontaneous clearance rates of recently acquired hepatitis C virus in HIV-positive MSM (The PROBE-C Study).
    Clin Infect Dis. 2022 Aug 25. pii: 6675078. doi: 10.1093.
    PubMed     Abstract available


  284. KAGUJJE M, Kerkhoff AD, Nteeni M, Dunn I, et al
    The performance of computer-aided detection digital chest X-ray reading technologies for triage of active Tuberculosis among persons with a history of previous Tuberculosis.
    Clin Infect Dis. 2022 Aug 25. pii: 6675069. doi: 10.1093.
    PubMed     Abstract available


  285. FISHER BT, Boge CLK, Xiao R, Shuster S, et al
    Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents.
    Clin Infect Dis. 2022;75:248-259.
    PubMed     Abstract available


  286. DERESINSKI S
    A Nasty Human Immunodeficiency Virus Type 1 (HIV-1) Variant.
    Clin Infect Dis. 2022;75:i-ii.
    PubMed    


  287. ROWLINSON E, Soge OO, Hughes JP, Berzkalns A, et al
    Prior exposure to azithromycin and azithromycin resistance among persons diagnosed with Neisseria gonorrhoeae infection at a Sexual Health Clinic 2012-2019.
    Clin Infect Dis. 2022 Aug 24. pii: 6674668. doi: 10.1093.
    PubMed     Abstract available


  288. FERNANDEZ OE, Gudipati S, Ko D, Boucher A, et al
    Papillomatous Anogenital Lesions in a Patient With Human Immunodeficiency Virus.
    Clin Infect Dis. 2022;75:172-175.
    PubMed    


  289. MASIA M, Fernandez-Gonzalez M, Agullo V, Mascarell P, et al
    HIV-1 RNA levels in rectal and seminal compartments after switching to long-acting cabotegravir plus rilpivirine: a longitudinal study.
    Clin Infect Dis. 2022 Aug 20. pii: 6672706. doi: 10.1093.
    PubMed     Abstract available


  290. WAKE RM, Molloy SF, Jarvis JN, Harrison TS, et al
    Cryptococcal Antigenemia in Advanced HIV: Pathophysiology, Epidemiology and Clinical Implications.
    Clin Infect Dis. 2022 Aug 20. pii: 6672680. doi: 10.1093.
    PubMed     Abstract available


  291. MARQUEZ C, Chen Y, Atukunda M, Chamie G, et al
    The Association Between Social Network Characteristics and Tuberculosis Infection Among Adults in Nine Rural Ugandan Communities.
    Clin Infect Dis. 2022 Aug 19. pii: 6671580. doi: 10.1093.
    PubMed     Abstract available


  292. DHARAN NJ, Jin F, Vaccher S, Bavinton B, et al
    Characteristics of HIV seroconversions in a large prospective implementation cohort study of oral HIV pre-exposure prophylaxis in men who have sex with men (EPIC-NSW).
    Clin Infect Dis. 2022 Aug 19. pii: 6671581. doi: 10.1093.
    PubMed     Abstract available


  293. MASTROROSA I, Pinnetti C, Brita AC, Mondi A, et al
    Declining prevalence of HIV-associated neurocognitive disorders in more recent years and associated factors, in a large cohort of ART-treated HIV-infected individuals.
    Clin Infect Dis. 2022 Aug 19. pii: 6671582. doi: 10.1093.
    PubMed     Abstract available


  294. SIBERRY GK, Mofenson LM, Calmy A, Reddy UM, et al
    Use of Ritonavir-boosted Nirmatrelvir in Pregnancy.
    Clin Infect Dis. 2022 Aug 17. pii: 6668958. doi: 10.1093.
    PubMed    


  295. SCHNITTMAN SR, Lu MT, Mayrhofer T, Burdo TH, et al
    Cytomegalovirus IgG Titer and Coronary Artery Disease in People with HIV.
    Clin Infect Dis. 2022 Aug 17. pii: 6668874. doi: 10.1093.
    PubMed     Abstract available


  296. OURSLER KK, Marconi VC, Wang Z, Xu K, et al
    Epigenetic Age Acceleration Markers Are Associated with Physiologic Frailty and All-cause Mortality in People with HIV.
    Clin Infect Dis. 2022 Aug 16. pii: 6667629. doi: 10.1093.
    PubMed     Abstract available


  297. PERSON AK, Armstrong WS, Evans T, Fangman JJ, et al
    Principles for Ending HIV as an Epidemic in the United States: A Policy Paper of IDSA and HIVMA.
    Clin Infect Dis. 2022 Aug 15. pii: 6662275. doi: 10.1093.
    PubMed     Abstract available


  298. PROSTY C, Hanula R, Levin Y, Bogoch II, et al
    Revisiting the Evidence Base for Modern Day Practice of the Treatment of Toxoplasmic Encephalitis: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2022 Aug 9. pii: 6659053. doi: 10.1093.
    PubMed     Abstract available


  299. BUNJUN R, Ramla TF, Jaumdally SZ, Noel-Romas L, et al
    Initiating Intramuscular Depot Medroxyprogesterone Acetate (DMPA-IM) Increases Frequencies of Th17-like Human Immunodeficiency Virus (HIV) Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial.
    Clin Infect Dis. 2022 Aug 9. pii: 6658490. doi: 10.1093.
    PubMed     Abstract available


  300. MOESTRUP KS, Reekie J, Zucco AG, Jensen TO, et al
    Readmissions, post-discharge mortality and sustained recovery among patients admitted to hospital with COVID-19.
    Clin Infect Dis. 2022 Aug 8. pii: 6658187. doi: 10.1093.
    PubMed     Abstract available


  301. KLEYNHANS J, Walaza S, Martinson NA, Neti M, et al
    Household transmission of SARS-CoV-2 from adult index cases living with and without HIV in South Africa, 2020-2021: a case-ascertained, prospective observational household transmission study.
    Clin Infect Dis. 2022 Aug 4. pii: 6655792. doi: 10.1093.
    PubMed     Abstract available


  302. YOON H, Wake RM, Nakouzi AS, Wang T, et al
    The association of antibody immunity with cryptococcal antigenemia and mortality in a South African cohort with advanced HIV disease.
    Clin Infect Dis. 2022 Aug 2. pii: 6653153. doi: 10.1093.
    PubMed     Abstract available


  303. CHRISTOPOULOS KA, Grochowski J, Mayorga-Munoz F, Hickey MD, et al
    First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable HIV Viremia in an Urban HIV Clinic.
    Clin Infect Dis. 2022 Aug 1. pii: 6652895. doi: 10.1093.
    PubMed     Abstract available


    July 2022
  304. MONTEJANO R, de la Calle-Prieto F, Velasco M, Guijarro C, et al
    Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe COVID-19: The PANCOVID Randomized Clinical Trial.
    Clin Infect Dis. 2022 Jul 30. pii: 6652179. doi: 10.1093.
    PubMed     Abstract available


  305. MARTINEZ-SANZ J, Serrano-Villar S, Muriel A, Fraile LJG, et al
    Metabolic-related outcomes after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in adults with HIV: a multicenter prospective cohort study.
    Clin Infect Dis. 2022 Jul 29. pii: 6651472. doi: 10.1093.
    PubMed     Abstract available


  306. PETERS BA, Hanna DB, Sharma A, Anastos K, et al
    Menopausal hormone therapy and subclinical cardiovascular disease in women with and without HIV.
    Clin Infect Dis. 2022 Jul 29. pii: 6651468. doi: 10.1093.
    PubMed     Abstract available


  307. HUDSON AG, Bonacci RA, Moorman AC, Penley M, et al
    Hepatitis C virus infection preceding an outbreak of HIV among persons who inject drugs- Kanawha County, West Virginia, 2019-2021.
    Clin Infect Dis. 2022 Jul 29. pii: 6651445. doi: 10.1093.
    PubMed     Abstract available


  308. BUI HTM, Adamson PC, Le GM, Klausner JD, et al
    Pharyngeal Chlamydia trachomatis in Men Who Have Sex With Men in an HIV Pre-Exposure Prophylaxis Program in Hanoi, Vietnam.
    Clin Infect Dis. 2022 Jul 27. pii: 6650382. doi: 10.1093.
    PubMed    


  309. CHAPLIN B, Agbaji O, Nieva HR, Olatunde B, et al
    The Timeliness of Point of Care Viral Load Results Improves HIV Monitoring in Nigeria.
    Clin Infect Dis. 2022 Jul 24. pii: 6649441. doi: 10.1093.
    PubMed     Abstract available


  310. WEI F, Goodman MT, Xia N, Zhang J, et al
    Incidence and clearance of anal human papillomavirus infection in 16 164 individuals, according to HIV status, gender, and male sexuality: an international pooled analysis of 34 longitudinal studies.
    Clin Infect Dis. 2022 Jul 23. pii: 6649069. doi: 10.1093.
    PubMed     Abstract available


  311. PESKO B, Deng A, Chan JD, Neme S, et al
    Safety, and Tolerability of Paxlovid (nirmatrelvir/ritonavir) in High Risk Patients.
    Clin Infect Dis. 2022 Jul 23. pii: 6649072. doi: 10.1093.
    PubMed    


  312. CHANG C, Agbaji O, Mitruka K, Olatunde B, et al
    Clinical Outcomes in a Randomized Controlled Trial Comparing Point-of-Care Versus Standard HIV Viral Load Monitoring in Nigeria.
    Clin Infect Dis. 2022 Jul 22. pii: 6648552. doi: 10.1093.
    PubMed     Abstract available


  313. SEKAGGYA-WILTSHIRE C, Nabisere R, Musaazi J, Otaalo B, et al
    Decreased dolutegravir and efavirenz concentrations with preserved virological suppression in patients with TB and HIV receiving high-dose rifampicin.
    Clin Infect Dis. 2022 Jul 21. pii: 6647783. doi: 10.1093.
    PubMed     Abstract available


  314. LEVIN AE, Bangdiwala AS, Nalintya E, Kagimu E, et al
    Outpatient Cryptococcal Antigen Screening is Associated with Favorable Baseline Characteristics and Improved Survival in Persons with Cryptococcal Meningitis in Uganda.
    Clin Infect Dis. 2022 Jul 21. pii: 6647578. doi: 10.1093.
    PubMed     Abstract available


  315. MAPONGA TG, Jeffries M, Tegally H, Sutherland A, et al
    Persistent SARS-CoV-2 infection with accumulation of mutations in a patient with poorly controlled HIV infection.
    Clin Infect Dis. 2022 Jul 6. pii: 6632801. doi: 10.1093.
    PubMed     Abstract available


  316. BRADLEY H, Hall E, Asher A, Furukawa N, et al
    Estimated number of people who inject drugs in the United States.
    Clin Infect Dis. 2022 Jul 6. pii: 6628702. doi: 10.1093.
    PubMed     Abstract available


  317. BARRE T, Moinot L, Spire B, Protopopescu C, et al
    Integrating HIV-specific elements in the treatment of tobacco dependence.
    Clin Infect Dis. 2022 Jul 5. pii: 6629405. doi: 10.1093.
    PubMed    


  318. MARATHE G, Moodie EE, Brouillette MJ, Delaunay CL, et al
    Impact of HCV cure on depressive symptoms in the HIV-HCV co-infected population in Canada.
    Clin Infect Dis. 2022 Jul 5. pii: 6629407. doi: 10.1093.
    PubMed     Abstract available


  319. DANIEL KELLY J, Lu S, Anglin K, Garcia-Knight M, et al
    Magnitude and determinants of SARS-CoV-2 household transmission: a longitudinal cohort study.
    Clin Infect Dis. 2022 Jul 5. pii: 6631204. doi: 10.1093.
    PubMed     Abstract available


  320. SHAH N, Esber A, Sean Cavanaugh J, Agaba P, et al
    Transitioning women to first-line preferred TLD regimen is lagging in Sub-Saharan Africa.
    Clin Infect Dis. 2022 Jul 5. pii: 6631203. doi: 10.1093.
    PubMed     Abstract available


  321. RIDOLFI F, Peetluk L, Amorim G, Turner M, et al
    TB TREATMENT OUTCOMES IN BRAZIL: DIFFERENT PREDICTORS FOR EACH TYPE OF UNSUCCESSFUL OUTCOME.
    Clin Infect Dis. 2022 Jul 5. pii: 6631480. doi: 10.1093.
    PubMed     Abstract available


    June 2022
  322. MANION M, Boulougoura A, Naqvi N, Lage SL, et al
    Polyfunctional antigen specific CD4+/- T cell responses in Patients with HIV/AIDS and Histoplasmosis Immune Reconstitution Inflammatory Syndrome.
    Clin Infect Dis. 2022 Jun 29. pii: 6619620. doi: 10.1093.
    PubMed     Abstract available


  323. ANDAGALU B, Watson OJ, Onyango I, Opot B, et al
    Malaria Transmission Dynamics in High Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-lumefantrine in an Asymptomatic Population.
    Clin Infect Dis. 2022 Jun 29. pii: 6619621. doi: 10.1093.
    PubMed     Abstract available


  324. OH DY, Holzer M, Paraskevopoulou S, Trofimova M, et al
    Advancing Precision Vaccinology by Molecular and Genomic Surveillance of SARS-CoV-2 in Germany, 2021.
    Clin Infect Dis. 2022 Jun 25. pii: 6617635. doi: 10.1093.
    PubMed     Abstract available


  325. ARNALDO P, Mabunda N, Young PW, Tran T, et al
    Prevalence of SARS-CoV-2 antibodies in the Mozambican population: a cross-sectional Serologic study in three cities, July-August 2020.
    Clin Infect Dis. 2022 Jun 24. pii: 6617331. doi: 10.1093.
    PubMed     Abstract available


  326. MORROCCHI E, Pighi C, Pascucci GR, Cotugno N, et al
    Perinatally HIV-infected adolescents and young adults demonstrate distinct BNT162b2 mRNA COVID-19 vaccine immunogenicity.
    Clin Infect Dis. 2022 Jun 23. pii: 6615389. doi: 10.1093.
    PubMed     Abstract available


  327. STARGEL A, Taylor MM, Zansky S, Spencer K, et al
    Case Investigation and Contact Tracing Efforts from Health Departments in the United States, November 2020-December 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611688. doi: 10.1093.
    PubMed     Abstract available


  328. CACHAY ER, Gilbert T, Deiss R, Mathews WC, et al
    Shared Decision-Making Concerning Anal Cancer Screening in Persons with HIV.
    Clin Infect Dis. 2022 Jun 20. pii: 6611535. doi: 10.1093.
    PubMed     Abstract available


  329. CARRIM M, Tempia S, Thindwa D, Martinson NA, et al
    Unmasking pneumococcal carriage in a high HIV prevalence population in two community cohorts with a high prevalence of HIV in South Africa, 2016-2018: the PHIRST study.
    Clin Infect Dis. 2022 Jun 19. pii: 6611495. doi: 10.1093.
    PubMed     Abstract available


  330. CHAN P, Yoon B, Colby D, Kroon E, et al
    Immunological, Cognitive and Psychiatric Outcomes after Initiating EFV- and DTG-based Antiretroviral Therapy during Acute HIV Infection.
    Clin Infect Dis. 2022 Jun 10. pii: 6605344. doi: 10.1093.
    PubMed     Abstract available


  331. COLLINS LF, Christina Mehta C, Palella FJ, Fatade Y, et al
    THE EFFECT OF MENOPAUSAL STATUS, AGE, AND HIV ON NON-AIDS COMORBIDITY BURDEN AMONG U.S. WOMEN.
    Clin Infect Dis. 2022 Jun 10. pii: 6605115. doi: 10.1093.
    PubMed     Abstract available


  332. LEE K, You S, Li Y, Chesson H, et al
    Estimation of the Lifetime Quality-Adjusted Life Years (QALYs) Lost Due to Syphilis acquired in the United States in 2018.
    Clin Infect Dis. 2022 Jun 9. pii: 6605062. doi: 10.1093.
    PubMed     Abstract available


  333. NACHEGA JB, Sam-Agudu NA, Siedner MJ, Rosenthal PJ, et al
    Prioritizing Pregnant Women for Coronavirus Disease 2019 Vaccination in African Countries.
    Clin Infect Dis. 2022 Jun 8. pii: 6603568. doi: 10.1093.
    PubMed     Abstract available


  334. NACHEGA JB, Sam-Agudu NA, Machekano RN, Rosenthal PJ, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis.
    Clin Infect Dis. 2022 Jun 8. pii: 6603567. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  335. NASH D, Rane MS, Robertson MM, Chang M, et al
    SARS-CoV-2 incidence and risk factors in a national, community-based prospective cohort of U.S. adults.
    Clin Infect Dis. 2022 May 27. pii: 6594058. doi: 10.1093.
    PubMed     Abstract available


  336. SCEVOLA S, Imaz A, Cottrell ML, Niubo J, et al
    Doravirine Concentrations and HIV-1 RNA in the Genital Fluids of Virologically Suppressed Adults Switching to Doravirine plus Emtricitabine/Tenofovir Alafenamide.
    Clin Infect Dis. 2022 May 25. pii: 6591842. doi: 10.1093.
    PubMed     Abstract available


  337. RIDDELL AC, Kele B, Harris K, Bible J, et al
    Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease.
    Clin Infect Dis. 2022 May 25. pii: 6591841. doi: 10.1093.
    PubMed     Abstract available


  338. LACOURSE SM, Escudero JN, Mecha J, Warr AJ, et al
    Cumulative Mtb infection incidence (measured primarily by TST) among infants with HIV exposure: observational follow-up of an isoniazid prophylaxis trial.
    Clin Infect Dis. 2022 May 24. pii: 6590981. doi: 10.1093.
    PubMed     Abstract available


  339. WANG RJ, Nouraie M, Kunisaki KM, Huang L, et al
    Lung Function in Women with and without HIV.
    Clin Infect Dis. 2022 May 23. pii: 6590818. doi: 10.1093.
    PubMed     Abstract available


  340. BROWNE SH, Vaida F, Umlauf A, Tucker AJ, et al
    Supporting the Art: Medication Adherence Patterns in Persons Prescribed Ingestible Sensor-enabled Oral Pre-Exposure Prophylaxis to Prevent Human Immunodeficiency Virus (HIV) Infection.
    Clin Infect Dis. 2022 May 23:ciac280. doi: 10.1093.
    PubMed     Abstract available


  341. TORDOFF DM, Dombrowski JC, Ramchandani MS, Barbee LA, et al
    Trans-inclusive Sexual Health Questionnaire to Improve HIV/STI Care for Transgender Patients: Anatomic-site Specific STI Prevalence & Screening Rates.
    Clin Infect Dis. 2022 May 20. pii: 6589775. doi: 10.1093.
    PubMed     Abstract available


  342. KAMAU E, Chaudhury S, Bolton JS, Slike BM, et al
    Susceptibility to HIV-1 Acquisition linked to Malaria Exposure: A Case-control Study.
    Clin Infect Dis. 2022 May 20. pii: 6589785. doi: 10.1093.
    PubMed     Abstract available


  343. COX H, Workman L, Bateman L, Franckling-Smith Z, et al
    Oral swabs tested with Xpert MTB/RIF Ultra for diagnosis of pulmonary tuberculosis in children: a diagnostic accuracy study.
    Clin Infect Dis. 2022 May 17. pii: 6586837. doi: 10.1093.
    PubMed     Abstract available


  344. WEITZMAN ER, Sherman AC, Levy O
    Pediatric SARS-CoV-2 Vaccines: Perceptions and Attitudes from the FDA Public Commentary.
    Clin Infect Dis. 2022 May 17. pii: 6586838. doi: 10.1093.
    PubMed     Abstract available


  345. O'HALLORAN JA, Sahrmann J, Parra-Rodriguez L, Vo DT, et al
    Integrase Strand Transfer Inhibitors are Associated with Incident Diabetes Mellitus in People with HIV.
    Clin Infect Dis. 2022 May 6. pii: 6581614. doi: 10.1093.
    PubMed     Abstract available


  346. LE V, Pascopella L, Westenhouse J, Barry P, et al
    A cross-sectional study of patients with extrapulmonary tuberculosis and normal chest radiographs - what characteristics were associated with sputum culture positivity?
    Clin Infect Dis. 2022 May 6. pii: 6581570. doi: 10.1093.
    PubMed     Abstract available


  347. PRICE JC, Ma Y, Kuniholm MH, Adimora AA, et al
    HIV is associated with elevated FibroScan-AST (FAST) score.
    Clin Infect Dis. 2022 May 3. pii: 6577095. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  348. PODELL BK, Aibana O, Huang CC, DiLisio JE, et al
    The Impact of Vitamin A Deficiency on Tuberculosis Progression.
    Clin Infect Dis. 2022 Apr 29. pii: 6576158. doi: 10.1093.
    PubMed     Abstract available


  349. YOUNG MR, Broadwell C, Kacanek D, Chadwick EG, et al
    Sexually transmitted infections in pregnant people living with HIV: Temporal trends, demographic correlates and association with preterm birth.
    Clin Infect Dis. 2022 Apr 29. pii: 6576157. doi: 10.1093.
    PubMed     Abstract available


  350. SEIDMAN D, Logan R, Weber S, Gandhi A, et al
    Reimagining Preexposure Prophylaxis Provision for Women in the United States.
    Clin Infect Dis. 2022 Apr 28. pii: 6432205. doi: 10.1093.
    PubMed     Abstract available


  351. NGUYEN H, Hampel B, Nunez DG, Battegay M, et al
    Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group.
    Clin Infect Dis. 2022 Apr 27. pii: 6575499. doi: 10.1093.
    PubMed    


  352. CAMPBELL JR, Chan ED, Falzon D, Trajman A, et al
    Low Body Mass Index at Treatment Initiation and Rifampicin-Resistant Tuberculosis Treatment Outcomes: An Individual Participant Data Meta-Analysis.
    Clin Infect Dis. 2022 Apr 27. pii: 6574751. doi: 10.1093.
    PubMed     Abstract available


  353. GARCIA-CREMADES M, Vucicevic K, Hendrix CW, Jayachandran P, et al
    Characterizing HIV-preventive, plasma tenofovir concentrations. A pooled participant-level data analysis from HIV pre-exposure prophylaxis (PrEP) clinical trials.
    Clin Infect Dis. 2022 Apr 26. pii: 6574602. doi: 10.1093.
    PubMed     Abstract available


  354. SHERMAN AC, Rouphael N, Baden LR
    COVID-19 Vaccine Trials (and Tribulations): How to improve the process of clinical trials in a pandemic.
    Clin Infect Dis. 2022 Apr 18. pii: 6569988. doi: 10.1093.
    PubMed     Abstract available


  355. BARROSO LF, Stier EA, Hillman R, Palefsky J, et al
    Anal Cancer Screening and Prevention: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Guidelines.
    Clin Infect Dis. 2022;74.
    PubMed     Abstract available


  356. SPAULDING AC, Rabeeah Z, Del Mar Gonzalez-Montalvo M, Akiyama MJ, et al
    Prevalence and Management of Sexually Transmitted Infections in Correctional Settings: A Systematic Review.
    Clin Infect Dis. 2022;74.
    PubMed     Abstract available


  357. KISSINGER PJ, Gaydos CA, Sena AC, Scott McClelland R, et al
    Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
    Clin Infect Dis. 2022;74.
    PubMed     Abstract available


  358. MCNEIL CJ, Kirkcaldy RD, Workowski K
    Enteric Infections in Men Who Have Sex With Men.
    Clin Infect Dis. 2022;74.
    PubMed     Abstract available


  359. BARBEE LA, St Cyr SB
    Management of Neisseria gonorrhoeae in the United States: Summary of Evidence From the Development of the 2020 Gonorrhea Treatment Recommendations and the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Treatment Guideli
    Clin Infect Dis. 2022;74.
    PubMed     Abstract available


  360. TUDDENHAM S, Ghanem KG
    Management of Adult Syphilis: Key Questions to Inform the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
    Clin Infect Dis. 2022;74.
    PubMed     Abstract available


  361. MUZNY CA, Balkus J, Mitchell C, Sobel JD, et al
    Diagnosis and Management of Bacterial Vaginosis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
    Clin Infect Dis. 2022;74.
    PubMed     Abstract available


  362. NYIRJESY P, Brookhart C, Lazenby G, Schwebke J, et al
    Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines.
    Clin Infect Dis. 2022;74.
    PubMed     Abstract available


  363. WORKOWSKI KA, Bachmann LH
    Centers for Disease Control and Prevention's Sexually Transmitted Diseases Infection Guidelines.
    Clin Infect Dis. 2022;74.
    PubMed    


  364. GEISLER WM, Hocking JS, Darville T, Batteiger BE, et al
    Diagnosis and Management of Uncomplicated Chlamydia trachomatis Infections in Adolescents and Adults: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
    Clin Infect Dis. 2022;74.
    PubMed     Abstract available


  365. STRAIN JF, Cooley S, Kilgore C, Nelson B, et al
    The Structural and Functional Correlates of Frailty in Persons Living With HIV.
    Clin Infect Dis. 2022 Apr 11. pii: 6566320. doi: 10.1093.
    PubMed     Abstract available


  366. KUSEJKO K, Salazar-Vizcaya L, Shah C, Stockle M, et al
    Sustained effect on hepatitis C elimination among men who have sex with men in the Swiss HIV Cohort Study: A systematic re-screening for hepatitis C RNA two years following a nation-wide elimination program.
    Clin Infect Dis. 2022 Apr 11. pii: 6566325. doi: 10.1093.
    PubMed     Abstract available


  367. ADES AE, Gordon F, Scott K, Collins IJ, et al
    Overall vertical transmission of HCV, transmission net of clearance, and timing of transmission.
    Clin Infect Dis. 2022 Apr 11. pii: 6566315. doi: 10.1093.
    PubMed     Abstract available


  368. SKEGGS J, MacPhail A, Korman T, Woolley I, et al
    Reductions in Antibiotic Prescribing in Australia During the SARS-CoV-2 Pandemic: National Prescribing Data.
    Clin Infect Dis. 2022 Apr 11. pii: 6566296. doi: 10.1093.
    PubMed    


  369. RASMUSSEN TA, Ahuja SK, Kuwanda L, Vjecha MJ, et al
    Antiretroviral initiation at >/=800 CD4+ cells/ mm 3 associated with lower HIV reservoir size.
    Clin Infect Dis. 2022 Apr 9. pii: 6565728. doi: 10.1093.
    PubMed     Abstract available


  370. GRAVETT RM, Cleveland JD, Overton ET, Marrazzo J, et al
    Bacterial STI Incidence among Southern MSM Living with HIV in the Treatment as Prevention Era, 2014-2019.
    Clin Infect Dis. 2022 Apr 5. pii: 6563777. doi: 10.1093.
    PubMed     Abstract available


  371. HUGHES JA, Solans BP, Draper HR, Schaaf HS, et al
    Pharmacokinetics and Safety of Bedaquiline in HIV-Positive and Negative Older Children and Adolescents with Rifampicin-Resistant Tuberculosis.
    Clin Infect Dis. 2022 Apr 4. pii: 6563170. doi: 10.1093.
    PubMed     Abstract available


  372. ANTINORI A, Cicalini S, Meschi S, Bordoni V, et al
    Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with current CD4 T-lymphocyte count.
    Clin Infect Dis. 2022 Apr 2. pii: 6562777. doi: 10.1093.
    PubMed     Abstract available


  373. HOLZMAN SB, Perry A, Saleeb P, Pyan A, et al
    Evaluation of the latent tuberculosis care cascade among public health clinics in the United States.
    Clin Infect Dis. 2022 Apr 1. pii: 6562172. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  374. GARRETT N, Tapley A, Andriesen J, Seocharan I, et al
    High Asymptomatic Carriage with the Omicron Variant in South Africa.
    Clin Infect Dis. 2022 Mar 30. pii: 6556153. doi: 10.1093.
    PubMed     Abstract available


  375. NATHELLA PK, Moideen K, Viswanathan V, Sivakumar S, et al
    Heightened microbial translocation is a prognostic biomarker of recurrent tuberculosis.
    Clin Infect Dis. 2022 Mar 30. pii: 6555776. doi: 10.1093.
    PubMed     Abstract available


  376. AMIN J, Vaccher S, Templeton DJ, Bavinton B B, et al
    Low prior exposure and incidence of hepatitis C in HIV negative gay and bisexual men taking PrEP: findings from the EPIC-NSW prospective implementation study.
    Clin Infect Dis. 2022 Mar 30. pii: 6555792. doi: 10.1093.
    PubMed     Abstract available


  377. BATEMAN M, Wolf A, Chimukangara B, Brust JCM, et al
    Adherence measured using electronic dose monitoring is associated with emergent antiretroviral resistance and poor outcomes in patients co-infected with HIV/AIDS and multidrug-resistant tuberculosis.
    Clin Infect Dis. 2022 Mar 30. pii: 6555759. doi: 10.1093.
    PubMed     Abstract available


  378. LEE TH, Hunt CM, Maier MM, Lowy E, et al
    Hepatitis B Virus-Related Care Quality In Patients With Hepatitis B/Hiv Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study.
    Clin Infect Dis. 2022 Mar 29. pii: 6555659. doi: 10.1093.
    PubMed     Abstract available


  379. COHEN CM, Wentzensen N, Lahrmann B, Tokugawa D, et al
    Automated evaluation of p16/Ki-67 dual stain cytology as a biomarker for detection of anal precancer in MSM living with HIV.
    Clin Infect Dis. 2022 Mar 24. pii: 6553198. doi: 10.1093.
    PubMed     Abstract available


  380. MCCALLUM AD, Pertinez HE, Chirambo AP, Sheha I, et al
    High intrapulmonary rifampicin and isoniazid concentrations are associated with rapid sputum bacillary clearance in patients with pulmonary tuberculosis.
    Clin Infect Dis. 2022 Mar 23. pii: 6553299. doi: 10.1093.
    PubMed     Abstract available


  381. INAGAKI K, Bradbury RS, Hobbs CV
    Hospitalizations Associated with Strongyloidiasis in the United States, 2003-2018.
    Clin Infect Dis. 2022 Mar 21. pii: 6551689. doi: 10.1093.
    PubMed     Abstract available


  382. SURGERS L, Chiarabini T, Royer G, Rougier H, et al
    Evidence of sexual transmission of extended-spectrum beta-lactamase-producing Enterobacterales: a cross-sectional and prospective study.
    Clin Infect Dis. 2022 Mar 21. pii: 6551017. doi: 10.1093.
    PubMed     Abstract available


  383. WILKIN T, Chen H, Sahasrabuddhe V, Matining R, et al
    A randomized clinical trial of HPV test-and-treat as compared to cytology-based screening for prevention of cervical cancer among women living with HIV: AIDS Clinical Trials Group Protocol A5282.
    Clin Infect Dis. 2022 Mar 16. pii: 6549734. doi: 10.1093.
    PubMed     Abstract available


  384. DOERNBERG SB, Holubar M, Jain V, Weng Y, et al
    Incidence and prevalence of COVID-19 within a healthcare worker cohort during the first year of the SARS-CoV-2 pandemic.
    Clin Infect Dis. 2022 Mar 12. pii: 6547892. doi: 10.1093.
    PubMed     Abstract available


  385. WOLTER N, Tempia S, von Gottberg A, Bhiman JN, et al
    Seroprevalence of SARS-CoV-2 after the second wave in South Africa in HIV-infected and uninfected persons: a cross-sectional household survey.
    Clin Infect Dis. 2022 Mar 10. pii: 6546682. doi: 10.1093.
    PubMed     Abstract available


  386. BALCELLS ME, Le Corre N, Duran J, Ceballos ME, et al
    Reduced immune response to inactivated SARS-CoV-2 vaccine in a cohort of immunocompromised patients in Chile.
    Clin Infect Dis. 2022 Mar 7. pii: 6543937. doi: 10.1093.
    PubMed     Abstract available


  387. NAIDOO K, Moodley MC, Hassan-Moosa R, Dookie N, et al
    Recurrent subclinical tuberculosis among ART accessing participants: Incidence, clinical course, and outcomes.
    Clin Infect Dis. 2022 Mar 5. pii: 6542969. doi: 10.1093.
    PubMed     Abstract available


  388. SARAVOLATZ LD, Depcinski S, Sharma M
    Molnupiravir and Nirmatrelvir-Ritonavir: Oral COVID Antiviral Drugs.
    Clin Infect Dis. 2022 Mar 4. pii: 6542722. doi: 10.1093.
    PubMed     Abstract available


  389. SPINELLI MA, Le Tourneau N, Glidden DV, Hsu L, et al
    Impact of Multi-Component Support Strategies on HIV Virologic Suppression Rates during COVID-19: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2022 Mar 4. pii: 6542721. doi: 10.1093.
    PubMed     Abstract available


  390. DOLATSHAHI S, Butler AL, Siedner MJ, Ngonzi J, et al
    Altered maternal antibody profiles in women with HIV drive changes in transplacental antibody transfer.
    Clin Infect Dis. 2022 Mar 4. pii: 6542597. doi: 10.1093.
    PubMed     Abstract available


  391. LLIBRE JM, Brites C, Cheng CY, Osiyemi O, et al
    Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With HIV-1: Week 48 Results From the Phase 3, Non-inferiority SALSA Randomiz
    Clin Infect Dis. 2022 Mar 2. pii: 6541246. doi: 10.1093.
    PubMed     Abstract available


  392. LOOBY SE, Kantor A, Burdo TH, Currier JS, et al
    Factors Associated with Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People with HIV on Antiretroviral Therapy.
    Clin Infect Dis. 2022 Mar 2. pii: 6541259. doi: 10.1093.
    PubMed     Abstract available


  393. SPEICH B, Chammartin F, Abela IA, Amico P, et al
    Antibody response in immunocompromised patients after the administration of SARS-CoV-2 vaccine BNT162b2 or mRNA-1273: A randomised controlled trial.
    Clin Infect Dis. 2022 Mar 2. pii: 6540899. doi: 10.1093.
    PubMed     Abstract available


  394. WANG C, Schlub TE, Yu WH, Tan CS, et al
    Landscape of HIV neutralization susceptibilities across tissue reservoirs.
    Clin Infect Dis. 2022 Mar 2. pii: 6541151. doi: 10.1093.
    PubMed     Abstract available


  395. GANDHI M
    Immunity Against the Omicron Variant from Vaccination, Recovery or Both.
    Clin Infect Dis. 2022 Mar 2. pii: 6540839. doi: 10.1093.
    PubMed    


    February 2022
  396. TRICKEY A, Croxford S, Emanuel E, Ijaz S, et al
    The effectiveness of low dead space syringes for reducing the risk of hepatitis C virus acquisition among people who inject drugs - findings from a national survey in England, Wales, and Northern Ireland.
    Clin Infect Dis. 2022 Feb 20. pii: 6532589. doi: 10.1093.
    PubMed     Abstract available


  397. CLARK EH, Marquez C, Whitman JD, Bern C, et al
    Screening for Chagas disease should be included in entry-to-care testing for at-risk people with HIV living in the United States.
    Clin Infect Dis. 2022 Feb 18. pii: 6532039. doi: 10.1093.
    PubMed     Abstract available


  398. HAIDAR G, Agha M, Bilderback A, Lukanski A, et al
    Prospective evaluation of COVID-19 vaccine responses across a broad spectrum of immunocompromising conditions: the COVICS study.
    Clin Infect Dis. 2022 Feb 18. pii: 6530582. doi: 10.1093.
    PubMed     Abstract available


  399. SCULLY EP, Aga E, Tsibris A, Archin N, et al
    Impact of Tamoxifen on Vorinostat-Induced HIV Expression in Women on Antiretroviral Therapy (ACTG A5366:The MOXIE trial).
    Clin Infect Dis. 2022 Feb 17. pii: 6530348. doi: 10.1093.
    PubMed     Abstract available


  400. TESHALE EH, Roberts H, Gupta N, Jiles R, et al
    Characteristics of persons treated for hepatitis C using national pharmacy claims data, United States, 2014-2020.
    Clin Infect Dis. 2022 Feb 16. pii: 6529537. doi: 10.1093.
    PubMed     Abstract available


  401. SCHUMACHER CM, Thornton N, Wagner J, Tilchin C, et al
    Sexually Transmitted Infection Transmission Dynamics During the Coronavirus Disease 2019 (COVID-19) Pandemic Among Urban Gay, Bisexual, and Other Men Who Have Sex With Men.
    Clin Infect Dis. 2022 Feb 16. pii: 6520505. doi: 10.1093/cid/ciab1053.
    PubMed     Abstract available


  402. ERLANDSON KM, Fitch KV, McCallum SA, Ribaudo HJ, et al
    Geographical Differences in the Self-Reported Functional Impairment of People with HIV and Associations with Cardiometabolic Risk.
    Clin Infect Dis. 2022 Feb 15. pii: 6528571. doi: 10.1093.
    PubMed     Abstract available


  403. BURZA S, Mahajan R, Kazmi S, Alexander N, et al
    AmBisome monotherapy and combination AmBisome - miltefosine therapy for the treatment of visceral leishmaniasis in patients co-infected with HIV in India: a randomised open label, parallel arm, phase 3 trial.
    Clin Infect Dis. 2022 Feb 11. pii: 6527047. doi: 10.1093.
    PubMed     Abstract available


  404. GORDON SC, Teshale EH, Spradling PR, Moorman AC, et al
    Lower rates of emergency visits and hospitalizations among chronic hepatitis C patients with sustained virological response to interferon-free direct-acting antiviral therapy (2014-2018).
    Clin Infect Dis. 2022 Feb 11. pii: 6526938. doi: 10.1093.
    PubMed     Abstract available


  405. LIEBENBERG LJP, Passmore JS, Osman F, Jewanraj J, et al
    Genital immune cell activation and tenofovir gel efficacy: a case-control study.
    Clin Infect Dis. 2022 Feb 10. pii: 6526223. doi: 10.1093.
    PubMed     Abstract available


  406. SHRESTHA S, Winglee K, Hill A, Shaw T, et al
    Model-based analysis of tuberculosis genotype clusters in the United States reveals high degree of heterogeneity in transmission, and state-level differences across California, Florida, New York, and Texas.
    Clin Infect Dis. 2022 Feb 10. pii: 6526443. doi: 10.1093.
    PubMed     Abstract available


  407. ERAUSQUIN JT, Tan RKJ, Uhlich M, Francis JM, et al
    The International Sexual Health And Reproductive Health Survey (I-SHARE-1): A Multi-Country Analysis of Adults from 30 Countries Prior to and During the Initial COVID-19 Wave.
    Clin Infect Dis. 2022 Feb 7. pii: 6523817. doi: 10.1093.
    PubMed     Abstract available


  408. BERANGER A, Bekker A, Solans BP, Cotton MF, et al
    Influence of NAT2 genotype and maturation on isoniazid exposure in low-birth-weight and preterm infants with or without HIV exposure.
    Clin Infect Dis. 2022 Feb 4. pii: 6522054. doi: 10.1093.
    PubMed     Abstract available


  409. MA J, Nance RM, Delaney JAC, Whitney BM, et al
    Current Antiretroviral Treatment Among People With Hiv In The Us: Findings From The Cnics Cohort.
    Clin Infect Dis. 2022 Feb 3. pii: 6521538. doi: 10.1093.
    PubMed     Abstract available


  410. BOURGI K, Kundu S, Stewart JC, So-Armah K, et al
    Associations of HIV and Depression with Incident Diabetes Mellitus: Veterans Aging Cohort Study.
    Clin Infect Dis. 2022 Feb 3. pii: 6521535. doi: 10.1093.
    PubMed     Abstract available


  411. MEIRING S, Tempia S, Bhiman JN, Buys A, et al
    Prolonged shedding of SARS-CoV-2 at high viral loads amongst hospitalised immunocompromised persons living with HIV, South Africa.
    Clin Infect Dis. 2022 Feb 2. pii: 6520530. doi: 10.1093.
    PubMed     Abstract available


  412. ROBERTS DA, Cuadros D, Vandormael A, Gareta D, et al
    Predicting the Risk of Hiv-1 Acquisition in Rural South Africa Using Geospatial Data.
    Clin Infect Dis. 2022 Feb 1. pii: 6518221. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  413. LU H, Cole SR, Westreich D, Hudgens MG, et al
    Corrigendum to: Clinical Effectiveness of Integrase Strand Transfer Inhibitor-Based Antiretroviral Regimens Among Adults With Human Immunodeficiency Virus: A Collaboration of Cohort Studies in the United States and Canada.
    Clin Infect Dis. 2022 Jan 31. pii: 6517847. doi: 10.1093.
    PubMed    


  414. GRIESEL R, Maartens G, Chirehwa M, Sokhela S, et al
    Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz.
    Clin Infect Dis. 2022 Jan 31. pii: 6517845. doi: 10.1093.
    PubMed    


  415. TSIKHUTSU I, Bii M, Dear N, Ganesan K, et al
    Prevalence and Correlates of Viral Load Suppression and HIV Drug Resistance Among Children and Adolescents in South Rift Valley and Kisumu, Kenya.
    Clin Infect Dis. 2022 Jan 29. pii: 6517349. doi: 10.1093.
    PubMed     Abstract available


  416. WESTON EJ, Heidenga BL, Farley MM, Tunali A, et al
    Surveillance for Disseminated Gonococcal Infections, Active Bacterial Core surveillance (ABCs) - United States, 2015-2019.
    Clin Infect Dis. 2022 Jan 28. pii: 6516834. doi: 10.1093.
    PubMed     Abstract available


  417. DIRAJLAL-FARGO S, Jacobson DL, Yu W, Mirza A, et al
    Gut dysfunction markers are associated with body composition in youth living with perinatally acquired HIV.
    Clin Infect Dis. 2022 Jan 28. pii: 6516818. doi: 10.1093.
    PubMed     Abstract available


  418. PEROFSKY AC, Tempia S, Bingham J, Maslo C, et al
    The direct and indirect effects of the COVID-19 pandemic on private healthcare utilization in South Africa, March 2020 - September 2021.
    Clin Infect Dis. 2022 Jan 27. pii: 6515907. doi: 10.1093.
    PubMed     Abstract available


  419. OSIYEMI O, De Wit S, Ajana F, Bisshop F, et al
    Efficacy and Safety of Switching to Dolutegravir/Lamivudine (DTG/3TC) Versus Continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With HIV-1: Results Through Week 144 From the Phase 3,
    Clin Infect Dis. 2022 Jan 25. pii: 6515475. doi: 10.1093.
    PubMed     Abstract available


  420. HUANG YA, Zhu W, Wiener J, Kourtis AP, et al
    Impact of COVID-19 on HIV Preexposure Prophylaxis Prescriptions in the United States - A Time Series Analysis.
    Clin Infect Dis. 2022 Jan 18. pii: 6510912. doi: 10.1093.
    PubMed     Abstract available


  421. LIU J, Laurie MT, Rubio L, Vazquez SE, et al
    SARS-CoV-2 transmission dynamics and immune responses in a household of vaccinated persons.
    Clin Infect Dis. 2022 Jan 17. pii: 6509064. doi: 10.1093.
    PubMed     Abstract available


  422. MUSSI-PINHATA MM, Ward S, Laimon L, Pelton SI, et al
    Effect of Maternal Vaccination of PCV-10, PPV-23 or Placebo on the Immunogenicity of PCV-10 in HIV-exposed Uninfected Infants: A Randomized Clinical Trial.
    Clin Infect Dis. 2022 Jan 17. pii: 6509061. doi: 10.1093.
    PubMed     Abstract available


  423. HUANG YA, Zhu W, Carnes N, Hoover KW, et al
    Abandonment of HIV preexposure prophylaxis prescriptions at retail pharmacies-United States, 2019.
    Clin Infect Dis. 2022 Jan 8. pii: 6501326. doi: 10.1093.
    PubMed     Abstract available


  424. TODD FOJO A, Wallengren E, Schnure M, Dowdy DW, et al
    Potential Effects of the COVID-19 Pandemic on HIV Transmission: A Modeling Study in 32 US Cities.
    Clin Infect Dis. 2022 Jan 7. pii: 6500774. doi: 10.1093/cid/ciab1029.
    PubMed     Abstract available


  425. JANI IV, Peter TF
    Nucleic Acid Point-of-Care Testing to Improve Diagnostic Preparedness.
    Clin Infect Dis. 2022 Jan 7. pii: 6500010. doi: 10.1093.
    PubMed     Abstract available


  426. SPINNER CD, Felizarta F, Rizzardini G, Philibert P, et al
    Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254.
    Clin Infect Dis. 2022 Jan 6. pii: 6498296. doi: 10.1093/cid/ciab1065.
    PubMed     Abstract available


  427. EDWARDS JK, Cole SR, Breger TL, Filiatreau LM, et al
    Mortality for adults entering HIV care under universal early treatment compared to the general US population.
    Clin Infect Dis. 2022 Jan 4. pii: 6496674. doi: 10.1093/cid/ciab1030.
    PubMed     Abstract available


  428. MAVE V, Chen L, Ranganathan UD, Kadam D, et al
    Whole Genome Sequencing Assessing Impact of Diabetes Mellitus on Tuberculosis Mutations and Type of Recurrence in India.
    Clin Infect Dis. 2022 Jan 4. pii: 6497515. doi: 10.1093/cid/ciab1067.
    PubMed     Abstract available


  429. ODAYAR J, Orrell C, Phillips TK, Hu NC, et al
    Use of tenofovir diphosphate levels to predict viremia during the postpartum period in women living with HIV: a nested case-control study.
    Clin Infect Dis. 2022 Jan 3. pii: 6494527. doi: 10.1093/cid/ciab1068.
    PubMed     Abstract available


  430. REDDY KP, Kruse GR, Lee S, Shuter J, et al
    Tobacco Use and Treatment of Tobacco Dependence Among People with HIV: A Practical Guide for Clinicians.
    Clin Infect Dis. 2022 Jan 3. pii: 6494528. doi: 10.1093/cid/ciab1069.
    PubMed     Abstract available


    December 2021
  431. MARTINSON NA, Lebina L, Webb EL, Ratsela A, et al
    Household contact tracing with intensified tuberculosis and HIV screening in South Africa: a cluster randomised trial.
    Clin Infect Dis. 2021 Dec 24. pii: 6482200. doi: 10.1093/cid/ciab1047.
    PubMed     Abstract available


  432. KHALIFE S, Jenkins HE, Dolynska M, Terleieva I, et al
    Incidence and Mortality of Extrapulmonary Tuberculosis in Ukraine: Analysis of National Surveillance Data.
    Clin Infect Dis. 2021 Dec 20. pii: 6470933. doi: 10.1093/cid/ciab1018.
    PubMed     Abstract available


  433. PODANY AT, Pham M, Sizemore E, Martinson N, et al
    Efavirenz pharmacokinetics and HIV-1 viral suppression among patients receiving TB treatment containing daily high-dose rifapentine.
    Clin Infect Dis. 2021 Dec 16. pii: 6464327. doi: 10.1093/cid/ciab1037.
    PubMed     Abstract available


  434. FILIPPIDIS P, Barras JL, Cavassini M, Kritikos A, et al
    A 31-Year-Old Patient Living With Human Immunodeficiency Virus With Thyroiditis and Multiple Intrathoracic Lesions.
    Clin Infect Dis. 2021;73:2361-2364.
    PubMed    


  435. MUDENDA V, Mumba C, Pieciak RC, Mwananyanda L, et al
    Histopathological Evaluation of Deceased Persons in Lusaka, Zambia With or Without Coronavirus Disease 2019 (COVID-19) Infection: Results Obtained From Minimally Invasive Tissue Sampling.
    Clin Infect Dis. 2021;73.
    PubMed     Abstract available


  436. LETANG E, Rakislova N, Martinez MJ, Carlos Hurtado J, et al
    Minimally Invasive Tissue Sampling: A Tool to Guide Efforts to Reduce AIDS-Related Mortality in Resource-Limited Settings.
    Clin Infect Dis. 2021;73.
    PubMed     Abstract available


  437. MUGO NR, Stalter RM, Heffron R, Rees H, et al
    Incidence of herpes simplex virus type 2 infection among African women using depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a nested randomized trial.
    Clin Infect Dis. 2021 Dec 15. pii: 6463091. doi: 10.1093/cid/ciab1027.
    PubMed     Abstract available


  438. SINHA P, Lakshminarayanan SL, Cintron C, Narasimhan PB, et al
    Nutritional Supplementation Would Be Cost-Effective for Reducing Tuberculosis Incidence and Mortality in India: The Ration Optimization to Impede Tuberculosis (ROTI-TB) model.
    Clin Infect Dis. 2021 Dec 15. pii: 6462896. doi: 10.1093/cid/ciab1033.
    PubMed     Abstract available


  439. KHAN K, Lustig G, Bernstein M, Archary D, et al
    Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV.
    Clin Infect Dis. 2021 Dec 10. pii: 6459255. doi: 10.1093/cid/ciab1008.
    PubMed     Abstract available


  440. HUANG YC, Sun HY, Sheng WH, Hsieh SM, et al
    Evolution of hepatitis B virus (HBV) serologic markers among antiretroviral-naive, young people living with HIV who had undergone neonatal HBV vaccination and initiated antiretroviral therapy.
    Clin Infect Dis. 2021 Dec 10. pii: 6459150. doi: 10.1093/cid/ciab1020.
    PubMed     Abstract available


  441. KHOSROPOUR CM, Soge OO, Golden MR, Hughes JP, et al
    Incidence and duration of pharyngeal chlamydia among a cohort of men who have sex with men.
    Clin Infect Dis. 2021 Dec 10. pii: 6459153. doi: 10.1093/cid/ciab1022.
    PubMed     Abstract available


  442. THOMPSON MA, Horberg MA, Agwu AL, Colasanti JA, et al
    Erratum to: Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America.
    Clin Infect Dis. 2021 Dec 8. pii: 6456476. doi: 10.1093.
    PubMed    


  443. CONWAY B
    Life-long Antiretroviral Therapy: Playing the Long Game.
    Clin Infect Dis. 2021;73:e3910-e3911.
    PubMed    


  444. FISH M, Shahvisi A, Gwaambuka T, Tangwa GB, et al
    Voluntary Medical Male Circumcision: Responding to Brian Morris.
    Clin Infect Dis. 2021;73:2152.
    PubMed    


  445. MOED S, Suprenant M, Odjidja EN, Meguid T, et al
    Economic Evaluation of Screening Interventions for Drug-induced Liver Injury.
    Clin Infect Dis. 2021;73:e3959-e3965.
    PubMed     Abstract available


  446. ZHOU Y, Wu D, Jiang H, Tang W, et al
    Challenges and Solutions for Scaling up Social Media-based Human Immunodefiency Virus (HIV) Self-testing: Author's Reply.
    Clin Infect Dis. 2021;73:e3878-e3989.
    PubMed    


  447. SPINELLI MA, Peluso MJ, Lynch KL, Yun C, et al
    Differences in Post-mRNA Vaccination SARS-CoV-2 IgG Concentrations and Surrogate Virus Neutralization Test Response by HIV Status and Type of Vaccine: a Matched Case-Control Observational Study.
    Clin Infect Dis. 2021 Dec 5. pii: 6453392. doi: 10.1093/cid/ciab1009.
    PubMed     Abstract available


  448. BUKKEMS VE, Necsoi C, Tenorio CH, Garcia C, et al
    Tenofovir alafenamide plasma concentrations are reduced in pregnant women living with HIV: data from the PANNA Network.
    Clin Infect Dis. 2021 Dec 5. pii: 6453382. doi: 10.1093/cid/ciab1010.
    PubMed     Abstract available


  449. ROMO ML, Edwards JK, Semeere AS, Musick BS, et al
    Viral load status before switching to dolutegravir-containing antiretroviral therapy and associations with HIV treatment outcomes in sub-Saharan Africa.
    Clin Infect Dis. 2021 Dec 5. pii: 6453480. doi: 10.1093/cid/ciab1006.
    PubMed     Abstract available


  450. JOSEPH NT, Satten GA, Williams RE, Haddad LB, et al
    The Effect of Antiretroviral Therapy for the Treatment of HIV-1 in Pregnancy on Gestational Weight Gain.
    Clin Infect Dis. 2021 Dec 3. pii: 6448917. doi: 10.1093.
    PubMed     Abstract available


  451. KIBUUKA H, Musingye E, Mwesigwa B, Semwogerere M, et al
    Predictors of All-Cause Mortality among People with HIV in a Prospective Cohort Study in East Africa and Nigeria.
    Clin Infect Dis. 2021 Dec 3. pii: 6448919. doi: 10.1093.
    PubMed     Abstract available


  452. GOVENDER I, Karat AS, Olivier S, Baisley K, et al
    Prevalence of Mycobacterium tuberculosis in sputum and reported symptoms among clinic attendees compared to a community survey in rural South Africa.
    Clin Infect Dis. 2021 Dec 3. pii: 6433207. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  453. MITCHELL KM, Maheu-Giroux M, Dimitrov D, Moore M, et al
    How can progress towards Ending the HIV Epidemic in the United States be monitored?
    Clin Infect Dis. 2021 Nov 26. pii: 6440758. doi: 10.1093.
    PubMed     Abstract available


  454. SLOGROVE AL, Burmen B, Davies MA, Edmonds A, et al
    Standardized Definitions of In Utero Human Immunodeficiency Virus and Antiretroviral Drug Exposure Among Children.
    Clin Infect Dis. 2021 Nov 23. pii: 6433692. doi: 10.1093.
    PubMed     Abstract available


  455. STRATHDEE SA, Abramovitz D, Harvey-Vera A, Vera CF, et al
    Correlates of Coronavirus Disease 2019 (COVID-19) Vaccine Hesitancy Among People Who Inject Drugs in the San Diego-Tijuana Border Region.
    Clin Infect Dis. 2021 Nov 22. pii: 6433374. doi: 10.1093.
    PubMed     Abstract available


  456. VAN RENSBURG R, Nightingale S, Brey N, Albertyn CH, et al
    Pharmacogenetics of the Late-Onset Efavirenz Neurotoxicity Syndrome (LENS).
    Clin Infect Dis. 2021 Nov 19. pii: 6432038. doi: 10.1093.
    PubMed     Abstract available


  457. HARRIS TG, Jaszi E, Lamb MR, Laudari CA, et al
    Effects of the COVID-19 Pandemic on HIV Services: Findings from 11 Sub-Saharan African Countries.
    Clin Infect Dis. 2021 Nov 15. pii: 6428385. doi: 10.1093.
    PubMed     Abstract available


  458. MENZA TW, Berry SA, Dombrowski J, Cachay E, et al
    Syphilis testing and diagnosis among people with HIV engaged in care at four United States clinical sites, 2014-2018.
    Clin Infect Dis. 2021 Nov 12. pii: 6426153. doi: 10.1093.
    PubMed     Abstract available


  459. ULFHAMMER G, Eden A, Antinori A, Brew BJ, et al
    Cerebrospinal Fluid viral load across the spectrum of untreated HIV-1 infection: a cross-sectional multi-center study.
    Clin Infect Dis. 2021 Nov 8. pii: 6423171. doi: 10.1093.
    PubMed     Abstract available


  460. WORETA TA, Chalasani N
    Fatty Liver Disease in Human Immunodeficiency Virus-Hepatitis B Virus Coinfection: A Cause for Concern.
    Clin Infect Dis. 2021;73:e3286-e3287.
    PubMed    


  461. ANSARI R, Rosen LB, Lisco A, Gilden D, et al
    Primary and Acquired Immunodeficiencies Associated With Severe Varicella-Zoster Virus Infections.
    Clin Infect Dis. 2021;73:e2705-e2712.
    PubMed     Abstract available


  462. MORTIMER TD, Pathela P, Crawley A, Rakeman JL, et al
    The Distribution and Spread of Susceptible and Resistant Neisseria gonorrhoeae Across Demographic Groups in a Major Metropolitan Center.
    Clin Infect Dis. 2021;73:e3146-e3155.
    PubMed     Abstract available


    October 2021
  463. CHIBWESHA CJ, Mollan KR, Ford CE, Shibemba A, et al
    A Randomized Trial of Point-of-Care Early Infant HIV Diagnosis in Zambia.
    Clin Infect Dis. 2021 Oct 29. pii: 6414399. doi: 10.1093.
    PubMed     Abstract available


  464. KUO PH, Wu UI, Pan YH, Wang JT, et al
    Neutralizing anti-GM-CSF autoantibodies in patients with CNS and localized cryptococcosis: a longitudinal follow-up and literature review.
    Clin Infect Dis. 2021 Oct 27. pii: 6412710. doi: 10.1093.
    PubMed     Abstract available


  465. KHALILI M, King WC, Kleiner DE, Chung RT, et al
    Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection.
    Clin Infect Dis. 2021 Oct 25. pii: 6410628. doi: 10.1093.
    PubMed     Abstract available


  466. HARNEY BL, Sacks-Davis R, van Santen DK, Traeger M, et al
    The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009-2019.
    Clin Infect Dis. 2021 Oct 25. pii: 6410633. doi: 10.1093.
    PubMed     Abstract available


  467. RAMIREZ PC, Diaz-Quijano FA
    Using a Composite Outcome in Estimating the Effect of Co-trimoxazole Prophylaxis on Prognosis in African Adults Receiving Antiretroviral Therapy.
    Clin Infect Dis. 2021;73:1550-1551.
    PubMed    


  468. DENTI P, Wasmann RE, van Rie A, Winckler J, et al
    Optimizing dosing and fixed-dose combinations of rifampicin, isoniazid, and pyrazinamide in pediatric patients with tuberculosis: a prospective population pharmacokinetic study.
    Clin Infect Dis. 2021 Oct 19. pii: 6403131. doi: 10.1093.
    PubMed     Abstract available


  469. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Severity, criticality, and fatality of the SARS-CoV-2 Beta variant.
    Clin Infect Dis. 2021 Oct 17. pii: 6398699. doi: 10.1093.
    PubMed     Abstract available


  470. HENDERSON HI, Napravnik S, Gower EW, Aiello AE, et al
    Resistance in Enterobacterales is higher among people with HIV.
    Clin Infect Dis. 2021 Oct 13. pii: 6395207. doi: 10.1093.
    PubMed     Abstract available


  471. PELUSO MJ, Thomas IJ, Munter SE, Deeks SG, et al
    Lack of Antinuclear Antibodies in Convalescent COVID-19 Patients with Persistent Symptoms.
    Clin Infect Dis. 2021 Oct 7. pii: 6383256. doi: 10.1093.
    PubMed    


  472. GIANELLA S, Rawlings SA, Nakazawa M, Chaillon A, et al
    Sex differences in HIV Persistence and Reservoir Size during Aging.
    Clin Infect Dis. 2021 Oct 6. pii: 6382188. doi: 10.1093.
    PubMed     Abstract available


  473. MCGINNIS KA, Justice AC, Moore RD, Silverberg MJ, et al
    Discrimination And Calibration Of The Vacs Index 2.0 For Predicting Mortality Among People With Hiv In North America.
    Clin Infect Dis. 2021 Oct 5. pii: 6381559. doi: 10.1093.
    PubMed     Abstract available


  474. MCCLUSKEY SM, Marconi VC
    High Baseline Viremia: An Achilles Heel for Integrase Inhibitor-Based Antiretroviral Therapy?
    Clin Infect Dis. 2021;73:e2142-e2144.
    PubMed    


  475. HELLMUTH J, Muccini C, Colby DJ, Kroon E, et al
    Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency Virus.
    Clin Infect Dis. 2021;73:e1885-e1892.
    PubMed     Abstract available


  476. MAURICE JB, Goldin R, Hall A, Price JC, et al
    Increased Body Mass Index and Type 2 Diabetes Are the Main Predictors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Liver Biopsies of Patients With Human Immunodeficiency Virus Monoinfection.
    Clin Infect Dis. 2021;73:e2184-e2193.
    PubMed     Abstract available


  477. KRAKOWER DS
    Human Immunodeficiency Virus Preexposure Prophylaxis: Meeting the Needs of Transgender Populations.
    Clin Infect Dis. 2021;73:e2124-e2126.
    PubMed    


  478. AJAYKUMAR A, Wong GC, Yindom LM, McHugh G, et al
    Shorter Granulocyte Telomeres Among Children and Adolescents With Perinatally Acquired Human Immunodeficiency Virus Infection and Chronic Lung Disease in Zimbabwe.
    Clin Infect Dis. 2021;73:e2043-e2051.
    PubMed     Abstract available


  479. SRINIVASAN S, Chambers LC, Tapia KA, Hoffman NG, et al
    Urethral Microbiota in Men: Association of Haemophilus influenzae and Mycoplasma penetrans With Nongonococcal Urethritis.
    Clin Infect Dis. 2021;73:e1684-e1693.
    PubMed     Abstract available


  480. HACKETT S, Teasdale CA, Pals S, Muttiti A, et al
    Drug Resistance Mutations Among South African Children Living With HIV on WHO-recommended ART Regimens.
    Clin Infect Dis. 2021;73:e2217-e2225.
    PubMed     Abstract available


  481. NEILAN AM, Bulteel AJB, Hosek SG, Foote JHA, et al
    Cost-effectiveness of Frequent HIV Screening Among High-risk Young Men Who Have Sex With Men in the United States.
    Clin Infect Dis. 2021;73:e1927-e1935.
    PubMed     Abstract available


  482. SCHACKMAN BR
    The Value and Challenge of Frequent Human Immunodeficiency Virus (HIV) Testing Among Young Men Who Have Sex With Men in the United States.
    Clin Infect Dis. 2021;73:e1936-e1937.
    PubMed    


  483. CHANDRA C, Weiss KM, Kelley CF, Marcus JL, et al
    Gaps in Sexually Transmitted Infection Screening Among Men who Have Sex with Men in Pre-exposure Prophylaxis (PrEP) Care in the United States.
    Clin Infect Dis. 2021;73:e2261-e2269.
    PubMed     Abstract available


  484. SAMET JH, Tsui JI, Cheng DM, Liebschutz JM, et al
    Improving the Delivery of Chronic Opioid Therapy Among People Living With Human Immunodeficiency Virus: A Cluster Randomized Clinical Trial.
    Clin Infect Dis. 2021;73:e2052-e2058.
    PubMed     Abstract available


  485. DEUTSCHMANN E, Bucher HC, Jaeckel S, Gibbons S, et al
    Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors.
    Clin Infect Dis. 2021;73:e2145-e2152.
    PubMed     Abstract available


  486. BARTLETT AW, Sudjaritruk T, Mohamed TJ, Anugulruengkit S, et al
    Identification, Management, and Outcomes of Combination Antiretroviral Treatment Failure in Adolescents With Perinatal Human Immunodeficiency Virus Infection in Asia.
    Clin Infect Dis. 2021;73:e1919-e1926.
    PubMed     Abstract available


  487. ZHAO R, Tao Y, Zhang L
    Can Social Media-Based Self-testing Be a New Paradigm for Human Immunodeficiency Virus Testing in China?
    Clin Infect Dis. 2021;73:e2258-e2260.
    PubMed    


  488. JACOBS P, Feaster DJ, Pan Y, Gooden LK, et al
    Initiation of Antiretroviral Therapy in the Hospital Is Associated With Linkage to Human Immunodeficiency Virus (HIV) Care for Persons Living With HIV and Substance Use Disorder.
    Clin Infect Dis. 2021;73:e1982-e1990.
    PubMed     Abstract available


  489. IMPERIAL MZ, Nedelman JR, Conradie F, Savic RM, et al
    Proposed linezolid dosing strategies to minimize adverse events for treatment of extensively drug-resistant tuberculosis.
    Clin Infect Dis. 2021 Oct 4. pii: 6380680. doi: 10.1093.
    PubMed     Abstract available


  490. SHARMA A, Hoover DR, Shi Q, Tien PC, et al
    HIV and Menopause are Independently Associated with Lower Bone Mineral Density: Results from the Women's Interagency HIV Study.
    Clin Infect Dis. 2021 Oct 1. pii: 6378735. doi: 10.1093.
    PubMed     Abstract available


  491. KONDA K, Kojima N, Vargas SK, Calvo G, et al
    Syphilis naive patients achieve treatment success more quickly: A comparison of time to syphilis treatment success in patients with repeat versus naive infection.
    Clin Infect Dis. 2021 Oct 1. pii: 6378906. doi: 10.1093.
    PubMed    


    September 2021
  492. LUNDBO LF, Harboe ZB, Sandholdt H, Smith-Hansen L, et al
    Comorbidity increases the risk of invasive meningococcal disease in adults.
    Clin Infect Dis. 2021 Sep 27. pii: 6375918. doi: 10.1093.
    PubMed     Abstract available


  493. SCHIM VAN DER LOEFF MF, Zondag H, Bruisten S, Jongen VW, et al
    Does Previous Syphilis Alter the Course of Subsequent Episodes of Syphilis?
    Clin Infect Dis. 2021 Sep 21. pii: 6373532. doi: 10.1093.
    PubMed    


  494. SACCENTE M, Krishnan G
    Comparison of Blood (1->3)-beta-d-Glucan Levels in AIDS-Related Pneumocystis jirovecii Pneumonia and AIDS-Related Progressive Disseminated Histoplasmosis.
    Clin Infect Dis. 2021;73:1100-1102.
    PubMed     Abstract available


    August 2021
  495. TULLY DC, Hahn JA, Bean DJ, Evans JL, et al
    Identification of Genetically Related HCV Infections Among Self-Described Injecting Partnerships.
    Clin Infect Dis. 2021 Aug 27. pii: 6358610. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  496. KIM S, Cohen T, Horsburgh CR, Miller JW, et al
    Trends, mechanisms, and racial/ethnic differences of tuberculosis incidence in the US-born population aged 50 years or older in the United States.
    Clin Infect Dis. 2021 Jul 29. pii: 6330597. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  497. LEIDI A, Koegler F, Dumont R, Dubos R, et al
    Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study.
    Clin Infect Dis. 2021 May 27. pii: 6287116. doi: 10.1093.
    PubMed     Abstract available


  498. MASSO-SILVA JA, Moshensky A, Lam MTY, Odish M, et al
    Increased peripheral blood neutrophil activation phenotypes and NETosis in critically ill COVID-19 patients: a case series and review of the literature.
    Clin Infect Dis. 2021 May 14. pii: 6275596. doi: 10.1093.
    PubMed     Abstract available


  499. TOY M, Hutton D, Harris AM, Nelson N, et al
    Cost-Effectiveness of One-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States.
    Clin Infect Dis. 2021 May 6. pii: 6270943. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  500. FACENTE SN, Patel S, Hecht J, Wilson E, et al
    Hepatitis C care cascades for three populations at high risk: low-income trans women, young people who inject drugs, and men who have sex with men and inject drugs.
    Clin Infect Dis. 2021 Mar 26. pii: 6188771. doi: 10.1093.
    PubMed     Abstract available


    December 2020
  501. PILAROWSKI G, Marquez C, Rubio L, Peng J, et al
    Field performance and public health response using the BinaxNOW TM Rapid SARS-CoV-2 antigen detection assay during community-based testing.
    Clin Infect Dis. 2020 Dec 26. pii: 6052342. doi: 10.1093/cid/ciaa1890.
    PubMed     Abstract available


    September 2020
  502. REBEIRO PF, Jenkins CA, Bian A, Lake JE, et al
    Risk of Incident Diabetes Mellitus, Weight Gain, and their Relationships with Integrase Inhibitor-based Initial Antiretroviral Therapy Among Persons with HIV in the US and Canada.
    Clin Infect Dis. 2020 Sep 16. pii: 5906580. doi: 10.1093/cid/ciaa1403.
    PubMed     Abstract available


  503. CARRERO A, Berenguer J, Hontanon V, Guardiola JM, et al
    Effects of HCV Eradication on Bone mineral density in HIV/HCV Coinfected Patients.
    Clin Infect Dis. 2020 Sep 15. pii: 5905898. doi: 10.1093/cid/ciaa1396.
    PubMed     Abstract available


  504. DOOKIE N, Padayatchi N, Naidoo K
    Tuberculosis Elimination in the Era of COVID-19: A Moving Target.
    Clin Infect Dis. 2020 Sep 14. pii: 5905579. doi: 10.1093/cid/ciaa1400.
    PubMed    


  505. DANDACHI D, Geiger G, Montgomery MW, Karmen-Tuohy S, et al
    Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients with HIV and Coronavirus Disease-19.
    Clin Infect Dis. 2020 Sep 9. pii: 5903368. doi: 10.1093/cid/ciaa1339.
    PubMed     Abstract available


  506. KOJIMA N, Klausner JD
    Patients may accurately self-collect pharyngeal and rectal specimens for Neisseria gonorrhoeae and Chlamydia trachomatis infection: But is there benefit?
    Clin Infect Dis. 2020 Sep 2. pii: 5900658. doi: 10.1093/cid/ciaa1272.
    PubMed    


  507. KHALILI M, King WC, Kleiner DE, Jain MK, et al
    Fatty Liver Disease in a Prospective North American Cohort of Adults with HIV and Hepatitis B Coinfection.
    Clin Infect Dis. 2020 Sep 1. pii: 5900012. doi: 10.1093/cid/ciaa1303.
    PubMed     Abstract available


    August 2020
  508. VENTER WDF, Nel J
    COVID-19: First data from Africa.
    Clin Infect Dis. 2020 Aug 31. pii: 5899682. doi: 10.1093/cid/ciaa1293.
    PubMed    


  509. BOULLE A, Davies MA, Hussey H, Ismail M, et al
    Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa.
    Clin Infect Dis. 2020 Aug 29. pii: 5899044. doi: 10.1093/cid/ciaa1198.
    PubMed     Abstract available


  510. MCCALLUM AD, Pertinez HE, Else LJ, Dilly-Penchala S, et al
    Intrapulmonary pharmacokinetics of first-line anti-TB drugs in Malawian tuberculosis patients.
    Clin Infect Dis. 2020 Aug 28. pii: 5898506. doi: 10.1093/cid/ciaa1265.
    PubMed     Abstract available


  511. MOOSA MS, Maartens G, Gunter H, Allie S, et al
    A Randomized Controlled Trial of Intravenous N-acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver Injury.
    Clin Infect Dis. 2020 Aug 26. pii: 5897464. doi: 10.1093/cid/ciaa1255.
    PubMed     Abstract available


  512. LEONARD MA, Cindi Z, Bradford Y, Bourgi K, et al
    Efavirenz Pharmacogenetics and Weight Gain following Switch to Integrase Inhibitor-containing Regimens.
    Clin Infect Dis. 2020 Aug 23. pii: 5896036. doi: 10.1093/cid/ciaa1219.
    PubMed     Abstract available


  513. HUANG J, Xie N, Hu X, Yan H, et al
    Epidemiological, virological and serological features of COVID-19 cases in people living with HIV in Wuhan City: A population-based cohort study.
    Clin Infect Dis. 2020 Aug 17. pii: 5893115. doi: 10.1093/cid/ciaa1186.
    PubMed     Abstract available


  514. CROWELL TA, Danboise B, Parikh A, Esber A, et al
    Pre-Treatment and Acquired Antiretroviral Drug Resistance among Persons Living with HIV in Four African Countries.
    Clin Infect Dis. 2020 Aug 12. pii: 5891786. doi: 10.1093/cid/ciaa1161.
    PubMed     Abstract available


  515. CAMPBELL JR, Al-Jahdali H, Bah B, Belo M, et al
    Safety and Efficacy of Rifampin or Isoniazid Among People with Mycobacterium tuberculosis Infection and Living with HIV or Other Health Conditions: Post-Hoc Analysis of Two Randomized Trials.
    Clin Infect Dis. 2020 Aug 12. pii: 5891810. doi: 10.1093/cid/ciaa1169.
    PubMed     Abstract available


  516. LU H, Cole SR, Westreich D, Hudgens MG, et al
    Clinical effectiveness of integrase strand transfer inhibitor-based antiretroviral regimens among adults with human immunodeficiency virus: a collaboration of cohort studies in the United States and Canada.
    Clin Infect Dis. 2020 Aug 11. pii: 5891141. doi: 10.1093/cid/ciaa1037.
    PubMed     Abstract available


  517. GRANT RM, Pellegrini M, Defechereux PA, Anderson PL, et al
    Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the iBrEATHe Study.
    Clin Infect Dis. 2020 Aug 8. pii: 5885191. doi: 10.1093/cid/ciaa1160.
    PubMed     Abstract available


  518. MARTINEZ L, Woldu H, Chen C, Hallowell BD, et al
    Transmission Dynamics in Tuberculosis Patients with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis of 32 Observational Studies.
    Clin Infect Dis. 2020 Aug 8. pii: 5889983. doi: 10.1093/cid/ciaa1146.
    PubMed     Abstract available


  519. CORMA-GOMEZ A, Macias J, Lacalle-Remigio JR, Tellez F, et al
    HIV infection is associated with lower risk of hepatocellular carcinoma after sustained virological response to direct-acting antivirals in hepatitis C infected-patients with advanced fibrosis.
    Clin Infect Dis. 2020 Aug 7. pii: 5885174. doi: 10.1093/cid/ciaa1111.
    PubMed     Abstract available


  520. BRAUN DL, Hampel B, Ledergerber B, Grube C, et al
    A treatment as prevention trial to eliminate hepatitis C among men who have sex with men living with HIV in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2020 Aug 6. pii: 5881825. doi: 10.1093/cid/ciaa1124.
    PubMed     Abstract available


  521. PETTIT AC, Stout JE, Belknap R, Benson CA, et al
    Optimal testing choice and diagnostic strategies for latent tuberculosis infection among U.S.-born people living with HIV.
    Clin Infect Dis. 2020 Aug 6. pii: 5881730. doi: 10.1093/cid/ciaa1135.
    PubMed     Abstract available


  522. ROCKSTROH JK
    Hepatitis C (HCV) microelimination in HIV-coinfected men who have sex with men (MSM): A low hanging fruit?
    Clin Infect Dis. 2020 Aug 5. pii: 5881444. doi: 10.1093/cid/ciaa1113.
    PubMed    


    July 2020
  523. ENGEL T, Raffenberg M, Schoepf IC, Kootstra NA, et al
    Telomere Length, Traditional Risk Factors, HIV-related Factors and Coronary Artery Disease Events in Swiss Persons Living with HIV.
    Clin Infect Dis. 2020 Jul 29. pii: 5877846. doi: 10.1093/cid/ciaa1034.
    PubMed     Abstract available


  524. WEINBERG A, Aaron L, Montepiedra G, Sterling TR, et al
    Effects of Pregnancy and Isoniazid Preventive Therapy on M. tuberculosis Interferon Gamma Response Assays in Women with HIV.
    Clin Infect Dis. 2020 Jul 28. pii: 5877271. doi: 10.1093/cid/ciaa1083.
    PubMed     Abstract available


  525. MITJA O, Corbacho-Monne M, Ubals M, Tebe C, et al
    Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial.
    Clin Infect Dis. 2020 Jul 16. pii: 5872589. doi: 10.1093/cid/ciaa1009.
    PubMed     Abstract available


    June 2020
  526. WU D, Zhou Y, Yang N, Huang S, et al
    Social media-based secondary distribution of HIV/syphilis self-testing among Chinese men who have sex with men.
    Clin Infect Dis. 2020 Jun 26. pii: 5863134. doi: 10.1093.
    PubMed     Abstract available


  527. JO Y, Shrestha S, Gomes I, Marks S, et al
    Model-Based Cost-Effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York and Texas.
    Clin Infect Dis. 2020 Jun 25. pii: 5862678. doi: 10.1093.
    PubMed     Abstract available


  528. PUYAT JH, Shulha HP, Balshaw R, Campbell JR, et al
    How well does TSTin3D predict risk of active tuberculosis in the Canadian immigrant population? An External Validation Study.
    Clin Infect Dis. 2020 Jun 18. pii: 5859579. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.